<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care - Weeks, G - 2016 | Cochrane Library</title> <meta content="Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care - Weeks, G - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011227.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care - Weeks, G - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011227.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011227.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care" name="citation_title"/> <meta content="Greg Weeks" name="citation_author"/> <meta content="greg@barwonhealth.org.au" name="citation_author_email"/> <meta content="Johnson George" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Katie Maclure" name="citation_author"/> <meta content="Robert Gordon University" name="citation_author_institution"/> <meta content="Derek Stewart" name="citation_author"/> <meta content="Robert Gordon University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD011227.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/11/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011227.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011227.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011227.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease [*therapy]; Blood Pressure; Chronic Disease [*drug therapy]; Developed Countries; Developing Countries; Diabetes Mellitus [drug therapy]; Drug Prescriptions [*standards]; Glycated Hemoglobin [analysis]; Interrupted Time Series Analysis; Lipoproteins, LDL [blood]; Medication Adherence; Patient Satisfaction; *Pharmacists; *Practice Patterns, Nurses'; Professional Autonomy; Quality of Life; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011227.pub2&amp;doi=10.1002/14651858.CD011227.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6zFwvAqw";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011227\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011227\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","fr","pl","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011227.pub2",title:"Non\\u2010medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care",firstPublishedDate:"Nov 22, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Effective Practice and Organisation of Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6zFwvAqw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011227.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011227.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011227.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011227.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011227.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011227.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011227.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011227.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011227.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011227.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>20977 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011227.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0119"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0055"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-sec-0113"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/appendices#CD011227-sec-0124"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/table_n/CD011227StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/table_n/CD011227StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#CD011227-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Greg Weeks</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#CD011227-cr-0003">Johnson George</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#CD011227-cr-0004">Katie Maclure</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information#CD011227-cr-0005">Derek Stewart</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information/en#CD011227-sec-0133">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 November 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011227.pub2">https://doi.org/10.1002/14651858.CD011227.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011227-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011227-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011227-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011227-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011227-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011227-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011227-abs-0001" lang="en"> <section id="CD011227-sec-0001"> <h3 class="title" id="CD011227-sec-0001">Background</h3> <p>A range of health workforce strategies are needed to address health service demands in low‐, middle‐ and high‐income countries. Non‐medical prescribing involves nurses, pharmacists, allied health professionals, and physician assistants substituting for doctors in a prescribing role, and this is one approach to improve access to medicines. </p> </section> <section id="CD011227-sec-0002"> <h3 class="title" id="CD011227-sec-0002">Objectives</h3> <p>To assess clinical, patient‐reported, and resource use outcomes of non‐medical prescribing for managing acute and chronic health conditions in primary and secondary care settings compared with medical prescribing (usual care). </p> </section> <section id="CD011227-sec-0003"> <h3 class="title" id="CD011227-sec-0003">Search methods</h3> <p>We searched databases including CENTRAL, MEDLINE, Embase, and five other databases on 19 July 2016. We also searched the grey literature and handsearched bibliographies of relevant papers and publications. </p> </section> <section id="CD011227-sec-0004"> <h3 class="title" id="CD011227-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs), cluster‐RCTs, controlled before‐and‐after (CBA) studies (with at least two intervention and two control sites) and interrupted time series analysis (with at least three observations before and after the intervention) comparing: 1. non‐medical prescribing versus medical prescribing in acute care; 2. non‐medical prescribing versus medical prescribing in chronic care; 3. non‐medical prescribing versus medical prescribing in secondary care; 4 non‐medical prescribing versus medical prescribing in primary care; 5. comparisons between different non‐medical prescriber groups; and 6. non‐medical healthcare providers with formal prescribing training versus those without formal prescribing training. </p> </section> <section id="CD011227-sec-0005"> <h3 class="title" id="CD011227-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. Two review authors independently reviewed studies for inclusion, extracted data, and assessed study quality with discrepancies resolved by discussion. Two review authors independently assessed risk of bias for the included studies according to EPOC criteria. We undertook meta‐analyses using the fixed‐effect model where studies were examining the same treatment effect and to account for small sample sizes. We compared outcomes to a random‐effects model where clinical or statistical heterogeneity existed. </p> </section> <section id="CD011227-sec-0006"> <h3 class="title" id="CD011227-sec-0006">Main results</h3> <p>We included 46 studies (37,337 participants); non‐medical prescribing was undertaken by nurses in 26 studies and pharmacists in 20 studies. In 45 studies non‐medical prescribing as a component of care was compared with usual care medical prescribing. A further study compared nurse prescribing supported by guidelines with usual nurse prescribing care. No studies were found with non‐medical prescribing being undertaken by other health professionals. The education requirement for non‐medical prescribing varied with country and location. </p> <p>A meta‐analysis of surrogate markers of chronic disease (systolic blood pressure, glycated haemoglobin, and low‐density lipoprotein) showed positive intervention group effects. There was a moderate‐certainty of evidence for studies of blood pressure at 12 months (mean difference (MD) ‐5.31 mmHg, 95% confidence interval (CI) ‐6.46 to ‐4.16; 12 studies, 4229 participants) and low‐density lipoprotein (MD ‐0.21, 95% CI ‐0.29 to ‐0.14; 7 studies, 1469 participants); we downgraded the certainty of evidence from high due to considerations of serious inconsistency (considerable heterogeneity), multifaceted interventions, and variable prescribing autonomy. A high‐certainty of evidence existed for comparative studies of glycated haemoglobin management at 12 months (MD ‐0.62, 95% CI ‐0.85 to ‐0.38; 6 studies, 775 participants). While there appeared little difference in medication adherence across studies, a meta‐analysis of continuous outcome data from four studies showed an effect favouring patient adherence in the non‐medical prescribing group (MD 0.15, 95% CI 0.00 to 0.30; 4 studies, 700 participants). We downgraded the certainty of evidence for adherence to moderate due to the serious risk of performance bias. While little difference was seen in patient‐related adverse events between treatment groups, we downgraded the certainty of evidence to low due to indirectness, as the range of adverse events may not be related to the intervention and selective reporting failed to adequately report adverse events in many studies. </p> <p>Patients were generally satisfied with non‐medical prescriber care (14 studies, 7514 participants). We downgraded the certainty of evidence from high to moderate due to indirectness, in that satisfaction with the prescribing component of care was only addressed in one study, and there was variability of satisfaction measures with little use of validated tools. A meta‐analysis of health‐related quality of life scores (SF‐12 and SF‐36) found a difference favouring non‐medical prescriber care for the physical component score (MD 1.17, 95% CI 0.16 to 2.17), and the mental component score (MD 0.58, 95% CI ‐0.40 to 1.55). However, the quality of life measurement may more appropriately reflect composite care rather than the prescribing component of care, and for this reason we downgraded the certainty of evidence to moderate due to indirectness of the measure of effect. A wide variety of resource use measures were reported across studies with little difference between groups for hospitalisations, emergency department visits, and outpatient visits. In the majority of studies reporting medication use, non‐medical prescribers prescribed more drugs, intensified drug doses, and used a greater variety of drugs compared to usual care medical prescribers. </p> <p>The risk of bias across studies was generally low for selection bias (random sequence generation), detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), and reporting bias (selective reporting). There was an unclear risk of selection bias (allocation concealment) and for other biases. A high risk of performance bias (blinding of participants and personnel) existed. </p> </section> <section id="CD011227-sec-0007"> <h3 class="title" id="CD011227-sec-0007">Authors' conclusions</h3> <p>The findings suggest that non‐medical prescribers, practising with varying but high levels of prescribing autonomy, in a range of settings, were as effective as usual care medical prescribers. Non‐medical prescribers can deliver comparable outcomes for systolic blood pressure, glycated haemoglobin, low‐density lipoprotein, medication adherence, patient satisfaction, and health‐related quality of life. It was difficult to determine the impact of non‐medical prescribing compared to medical prescribing for adverse events and resource use outcomes due to the inconsistency and variability in reporting across studies. Future efforts should be directed towards more rigorous studies that can clearly identify the clinical, patient‐reported, resource use, and economic outcomes of non‐medical prescribing, in both high‐income and low‐income countries. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011227-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011227-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011227-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011227-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011227-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011227-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011227-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011227-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011227-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011227-abs-0003" lang="en"> <h3>Prescribing roles for health professionals other than doctors</h3> <p><b>What is the aim of this review?</b> </p> <p>The aim of this Cochrane review was to find out if prescribing by health professionals other than doctors delivers comparable outcomes to prescribing by doctors. Cochrane researchers collected and analysed all relevant studies to answer this question and found 46 studies. </p> <p><b>Key messages</b> </p> <p>With appropriate training and support, nurses and pharmacists are able to prescribe medicines as part of managing a range of conditions to achieve comparable health management outcomes to doctors. The majority of studies focus on chronic disease management in higher‐income counties where there is generally a moderate‐certainty of evidence supporting similar outcomes for the markers of disease in high blood pressure, diabetes, and high cholesterol. Further high‐quality studies are needed in poorer countries and to better quantify differences in prescribing outcomes for adverse events, and to determine health economic outcomes. Further studies could also focus more specifically on the prescribing component of care. </p> <p><b>What was studied in the review?</b> </p> <p>A number of countries allow health professionals other than doctors to prescribe medicines. This shift in roles is thought to provide improved and timely access to medicines for consumers where there are shortages of doctors or the health system is facing pressures in coping with the burden of disease. In addition, this task shift has been supported by a number of governments as a way to more appropriately use the skills of health professionals, such as nurses and pharmacists, in the care of patients. We compared the outcomes of any healthcare workers who were prescribing with a high degree of autonomy with medical prescribers in the hospital or community setting in low‐, middle‐ and high‐income countries. </p> <p><b>What are the main results of the review?</b> </p> <p>This review found 45 studies where nurses and pharmacists with high levels of prescribing autonomy were compared with usual care medical prescribers. A further study compared nurse prescribing with guideline support with usual nurse prescribing care. No studies were found with other health professionals or lay prescribers. Four nurse prescribing studies were undertaken in the low‐ and middle‐income settings of Colombia, South Africa, Uganda, and Thailand. The remainder of studies were undertaken in high‐income Western countries. Forty‐two studies were based in a community setting, two studies were located in hospitals, one study in the workplace, and one study in an aged care facility. Prescribing was but one part of many health‐related interventions, particularly in the management of chronic disease. </p> <p>The review found that the outcomes for non‐medical prescribers were comparable to medical prescribers for: high blood pressure (moderate‐certainty of evidence); diabetes control (high‐certainty of evidence); high cholesterol (moderate‐certainty of evidence); adverse events (low‐certainty of evidence); patients adhering to their medication regimens (moderate‐certainty of evidence); patient satisfaction with care (moderate‐certainty of evidence); and health‐related quality of life (moderate‐certainty of evidence). </p> <p>Pharmacists and nurses with varying levels of undergraduate, postgraduate, and specific on‐the‐job training related to the disease or condition were able to deliver comparable prescribing outcomes to doctors. Non‐medical prescribers frequently had medical support available to facilitate a collaborative practice model. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The review authors searched for studies that had been published up to 19th July 2016.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011227-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011227-sec-0119"></div> <h3 class="title" id="CD011227-sec-0120">Implications for practice</h3> <section id="CD011227-sec-0120"> <p>Non‐medical prescribers practising in a variety of settings and with varying but high levels of prescribing autonomy, can achieve comparable outcomes in the management of chronic disease and preventive healthcare. Non‐medical prescribers can deliver comparable outcomes for systolic blood pressure, glycated haemoglobin, low‐density lipoprotein, medication adherence, patient satisfaction, and general quality of life. The certainty of evidence in studies reporting adverse events and resource use make it difficult to determine the impact of non‐medical prescribing compared to medical prescribing for these outcome measures. Pharmacists and nurses are able to deliver comparable prescribing outcomes with varying levels of undergraduate, postgraduate, and specific on‐the‐job training. Non‐medical prescribers frequently have medical support available, if needed, and where these circumstances exist, a collaborative approach appears the preferred model of care. Non‐medical prescribers across a range of different settings in low‐, medium‐ and high‐income countries may be able to meet the growing burden of chronic disease, or where doctor shortages or scarce health resources exist. </p> </section> <h3 class="title" id="CD011227-sec-0121">Implications for research</h3> <section id="CD011227-sec-0121"> <p>It is frequently difficult within collaborative care models to distinguish specific outcomes that can be related to the non‐medical prescribing component of care. There is a need for trials to more effectively control the variables around non‐medical prescribing to truly determine its effect compared to usual medical prescribing care. Outcomes should be clearly defined, studies should facilitate meta‐analysis, and more effectively quantify adverse prescribing events. Further studies on patient satisfaction using validated tools are required to identify satisfaction with the prescribing component of care. There were many parameters of resource use in the included studies, with few studies capturing comparative drug costs of non‐medical prescribing versus usual care medical prescribing. The cost of doctors' time saved and whether this time is transferred to more acute patient care should be quantified in future studies. Therefore, there is a need for cost‐effectiveness analysis of a range of non‐medical prescribing interventions. Well‐controlled studies are also required in the acute secondary care setting to establish the effect of non‐medical prescribing roles on medical workload, resource use, patient flow, and safety. Due to the limited number of studies in low‐ and middle‐income countries, further well‐controlled trials are required in such settings. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011227-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011227-sec-0015"></div> <div class="table" id="CD011227-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Non‐medical prescribing compared to medical prescribing for acute and chronic disease management in primary and secondary care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Non‐medical prescribing compared to medical prescribing for acute and chronic disease management in primary and secondary care</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute and chronic disease<br/> <b>Settings:</b> secondary care and ambulatory/primary care in low‐, middle‐ and high‐income counties<br/> <b>Intervention:</b> non‐medical prescribing<br/> <b>Comparison:</b> medical prescribing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Medical prescribing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Non‐medical prescribing</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure (mmHg) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure in the control group ranged from 124 mmHg to 149 mmHg </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure in the intervention group was 5.31 mmHg lower (‐6.46 lower to ‐4.16 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4229<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b> <br/> <sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random‐effects analysis: MD ‐5.91 mmHg lower (95% CI ‐7.71 lower to ‐4.10 lower)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Glycated haemoglobin (HbA1c, %) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in glycated haemoglobin in the control group ranged from ‐0.90% to 9.7% </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in glycated haemoglobin in the intervention group was 0.62% lower (‐0.85 lower to ‐0.38 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>775<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random‐effects analysis:</p> <p>MD ‐0.62 (95% CI ‐0.85 to ‐0.38)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low‐density lipoprotein (mmol/L) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein in the control group ranged from ‐0.26 to 3.41 mmol/L</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein in the intervention group was 0.21 mmol/L lower (‐0.29 lower to ‐0.14 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1469<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random‐effects analysis: MD ‐0.30 (95% CI ‐0.62 to 0.02)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence (continuous)</p> <p>6 months follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adherence (continuous) in the control group was 0.79</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adherence in the intervention group was 0.15 higher (0.00 higher to 0.30 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>700<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Patient satisfaction was reported in 14 studies (<a href="#CD011227-tbl-0005">Table 4</a>). The majority of surveys were either not referenced or developed locally. Validated questionnaires assessing overall non‐medical practitioner satisfaction with care were reported in six studies rather than patient satisfaction with prescribing. An exception was the study by <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>, which found for the prescribing intervention, patients were generally positive about the pharmacist prescribing service, 85% (39/46) were totally satisfied, while 9% (4/44) would have preferred to see their GP </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7514</p> <p>(14 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>8,9</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>There was little or no difference in adverse events between treatment groups in nine studies. Two studies reported higher rates of adverse events in the usual care group. It was difficult to determine effects in the remaining studies because limited data were reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18,400</p> <p>(18 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life measured with SF‐12/36</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health‐related quality of life in the control group was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health‐related quality of life in the intervention group:</p> <p>physical component was 1.17 higher (0.16 to 2.17)</p> <p>mental component was 0.58 higher (‐0.40 to 1.55)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4631<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>Moderate</b><sup>10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>GP</b> : general practitioner; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to serious inconsistency (considerable heterogeneity was found).<br/> <sup>2</sup>Multifaceted interventions.<br/> <sup>3</sup>Variable prescribing autonomy.<br/> <sup>4</sup>Downgraded one level due to serious risk of bias (high risk of performance bias).<br/> <sup>5</sup>Variable reporting measures of adherence.<br/> <sup>6</sup>Downgraded one level due to indirectness (range of adverse events; may not be related to the intervention).<br/> <sup>7</sup>Downgraded one level due to selective outcome reporting (adverse events not reported in many studies).<br/> <sup>8</sup>Downgraded one level due to indirectness (prescribing component not adequately assessed across studies).<br/> <sup>9</sup>Variability in satisfaction measures.<br/> <sup>10</sup>Downgraded one level due to indirectness (prescribing component effect on quality of life difficult to determine). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011227-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011227-sec-0016"></div> <section id="CD011227-sec-0017"> <h3 class="title" id="CD011227-sec-0017">Description of the healthcare challenge</h3> <p>A range of health workforce strategies are needed to address issues of health service access and efficiency. In low‐, middle‐ and high‐income countries, the increasing demand for health services arises from an ageing population and the resultant increasing burden of chronic disease (<a href="./references#CD011227-bbs2-0164" title="BhanbhroS , DrennanVM , GrantR , HarriosR . Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature. BMC Health Services Research2011;11:330. ">Bhanbhro 2011</a>; <a href="./references#CD011227-bbs2-0175" title="DuckettS . Health workforce design for the 21st century. Australian Health Review2005;29(2):201‐10. ">Duckett 2005</a>; <a href="./references#CD011227-bbs2-0200" title="PhillipsPA , HughesCF . Clinical process redesign ‐ can the leopard change its spots?. Medical Journal of Australia2008;188:S7‐8. ">Phillips 2008</a>; <a href="./references#CD011227-bbs2-0209" title="World Health Organization. World Health Statistics 2012. www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf. France, (accessed 10 Feb 2013). ">WHO 2012</a>). </p> <p>Increased health demands can be met in part by task substitution within the health workforce. One health workforce strategy for task substitution is to permit prescribing by healthcare providers other than medical doctors. Non‐medical prescribers may include nurses, pharmacists, allied health professionals, and physician assistants. In some low‐ and middle‐income countries, lay health workers have been used to distribute medications with preventive or curative intent, including contraceptives, iron or vitamin supplements, vaccinations, and agents for tuberculosis management (<a href="./references#CD011227-bbs2-0178" title="GlentonC , ColvinCJ , CarlsenB , SwartzA , LewinS , NoyesJ , et al. Barriers and facilitators to the implementation of lay health worker programmes to improve access to maternal and child health: qualitative evidence synthesis. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD010414.pub2] ">Glenton 2013</a>). </p> <p>Extending a health provider's scope of practice, including the right to prescribe, has been supported in a number of countries as a means of benefiting patient care by the effective use of health professionals' skills, improving patient access to timely care, improving patient choice, and enhancing teamwork and the better use of resources (<a href="./references#CD011227-bbs2-0171" title="Department of Health. Review of prescribing, supply and administration of medicines (the Crown Report). webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4077153.pdf (accessed 3 November 2012). ">Department of Health 1999</a>; <a href="./references#CD011227-bbs2-0176" title="EllisN , RobinsonL , BrooksP . Task substitution: where to from here?. Medical Journal of Australia2006;185(1):18‐9. ">Ellis 2006</a>; <a href="./references#CD011227-bbs2-0185" title="HookerR . Physician assistants and nurse practitioners: the United States experience. Medical Journal of Australia2006;185(1):4‐7. ">Hooker 2006</a>; <a href="./references#CD011227-bbs2-0204" title="StewartD , CunninghamS , DiackL , McCaigD , MacLureK , BondC , et al. Prescribing Research Group, NHS Education for Scotland. Report: Exploring and evaluating pharmacist prescribing. www.openair.rgu.ac.uk/handle/10059/1939 (accessed 12 Jan 2013). ">Stewart 2010</a>). </p> <p>The devolution of prescribing rights in high‐income countries has continued from a historical base in the United States of America (USA) in the 1970s through to more recent government‐led reforms in the United Kingdom (UK), Canada, the Netherlands, New Zealand, and Australia. While the definition of prescribing may vary between countries, for the purpose of our review, prescribing was defined as: "an iterative process involving the steps of information gathering, clinical decision making, communication and evaluation which results in the initiation, continuation or cessation of a medicine" (<a href="./references#CD011227-bbs2-0182" title="Health Workforce Australia. Health Professionals prescribing Pathway (HPPP) Project ‐Final Report. www.healthinfonet.ecu.edu.au/key‐resources/bibliography/?lid=26503 (accessed 30 November 2016). ">Health Workforce Australia 2013</a>). The term 'medical prescribing' refers to prescribing by medically qualified doctors. The supply of non‐prescription (over‐the‐counter) medicines by pharmacists or pharmacy assistants working in community pharmacies is excluded from our definition of prescribing, as is the supply of medicines by lay health workers. </p> <p>The term 'non‐medical prescribing' originates from the UK, where it is defined as: "prescribing by specially trained nurses, optometrists, pharmacists, physiotherapists, podiatrists, and radiographers, working within their clinical competence as either independent or supplementary prescribers" (<a href="./references#CD011227-bbs2-0196" title="National Prescribing Centre, National Institute for Health and Clinical Excellence. A single competency framework for all prescribers. www.associationforprescribers.org.uk/images/Single_Competency_Framework.pdf (accessed 30 October 2016). ">NPC 2012</a>). </p> <p>Supplementary prescribing which was introduced in the UK in 2003, is defined as 'a voluntary partnership between an independent prescriber (a doctor or dentist) and a supplementary prescriber (e.g. nurse, optometrist, pharmacist, physiotherapist, chiropodist/podiatrist, or radiographer) to implement an agreed patient‐specific clinical management plan with the patient's agreement' (<a href="./references#CD011227-bbs2-0172" title="Department of Health. Supplementary prescribing by nurses and pharmacists within the NHS in England. A guide for implementation. webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009717 (accessed 3 November 2012). ">Department of Health 2003</a>). Non‐medical prescribing rights were extended in 2006 with the introduction of independent prescribing. The UK Department of Health defines independent prescribing as 'prescribing by a practitioner (e.g. doctor, dentist, nurse, pharmacist, optometrist) responsible and accountable for the assessment of patients with undiagnosed or diagnosed conditions, and for decisions about the clinical management required, including prescribing'. Independent prescribing is one element of the clinical management of a patient and occurs in partnership with the patient. It requires an initial patient assessment, interpretation of that assessment, a decision on safe and appropriate therapy, and a process for ongoing monitoring. The independent prescriber is responsible and accountable for at least this element of a patient's care (<a href="./references#CD011227-bbs2-0173" title="Department of Health. Improving patients' access to medicines: A guide to implementing nurse and pharmacist independent prescribing within the NHS in England. April 2006. webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/PublicationsandStatistics/Publications/PublicationsPolicyandGuidance/DH_4133743 (accessed 3 November 2012). ">Department of Health 2006</a>). Independent prescribing does not require a clinical management plan. From 1 May 2006, nurse and pharmacist independent prescribers who completed the appropriate training could prescribe, with a few exceptions, any licensed medicine for any medical condition within their competence. In 2009, independent prescribing rights were extended to include unlicensed medicines. While prescribing of controlled drugs was restricted, this limitation was removed through legislative change in April 2012 (<a href="./references#CD011227-bbs2-0184" title="Home Office. Circular: nurse and pharmacist independent prescribing, 'mixing of medicines', possession authorities under patient group directions and personal exemption provisions for Schedule 4 Part II drugs. Home Office circular 009/2012. www.gov.uk/government/publications/nurse‐and‐pharmacist‐independent‐prescribing‐mixing‐of‐medicines‐possession‐authorities‐under‐patient‐group‐directions‐and‐personal‐exemption‐provisions‐for‐schedule‐4‐part‐ii‐drugs (accessed 12 January 2013). ">Home Office 2012</a>). </p> <p>In the USA, devolution of prescribing authority varies from state to state. Collaborative Practice Agreements in 46 States allow a pharmacist to partner with a physician to manage a number of patient services, including medication management (<a href="./references#CD011227-bbs2-0192" title="LawAV , GuptaEK , HessKM , KlotzRS , LeQA , SchwartzmanE , et al. Collaborative pharmacy practice: an update. Integrated Pharmacy Research Practice2013;2:1‐16. ">Law 2013</a>; <a href="./references#CD011227-bbs2-0205" title="ThomasJ , MurtuzaB , LinShu‐Wen , YogeshP . Survey of pharmacist collaborative drug therapy management in hospitals. American Journal of Health‐System Pharmacy2006;63:2489‐99. ">Thomas 2006</a>). Physician assistants and nurse practitioners were introduced in 1967 to support medical care. These practitioners undertake a range of clinical functions, including prescribing (<a href="./references#CD011227-bbs2-0185" title="HookerR . Physician assistants and nurse practitioners: the United States experience. Medical Journal of Australia2006;185(1):4‐7. ">Hooker 2006</a>). </p> <p>Within Canada, a pharmacist's scope of prescribing practice varies between the provinces from independently prescribing to adapting (modifying) or continuing prescriptions (<a href="./references#CD011227-bbs2-0191" title="LawM , MaT , FisherJ , SketrisI . Independent pharmacist prescribing in Canada. Canadian Pharmacists Journal2012;145(1):17‐23. ">Law 2012</a>). </p> <p>A collaborative prescribing model has emerged as the preferred model of practice within New Zealand and Australia. Collaborative prescribing is undertaken within a multidisciplinary team and can include the continuum of prescribing from transcription of orders (with or without medical signature), prescribing specified drugs and doses by protocol, prescribing by clinical management plan (allowing choice of drugs and doses) to independent prescribing, where a prescribing consultation with a medical practitioner is not required (<a href="./references#CD011227-bbs2-0207" title="WeeksGR , MarriottJL . Collaborative prescribing: Views of SHPA pharmacist members. Journal of Pharmacy Practice and Research2008;38:271‐5. ">Weeks 2008</a>; <a href="./references#CD011227-bbs2-0208" title="WheelerA , CrumpK , LeeM , LiL , PatelA , YangR , et al. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health. Research in Social and Administrative Pharmacy2012;8(3):179‐92. ">Wheeler 2012</a>). </p> <p>The Health Professionals Prescribing Pathway developed by Health Workforce Australia (HWA) includes five steps to safely and competently prescribe, and covers: education and training, recognition by the profession's national registering board, authorisation to prescribe by legislation, prescribing within the scope of practice, and maintaining and enhancing competence to prescribe. The prescribing models suggested by HWA emphasise team communication and are divided into autonomous prescribing, prescribing under supervision, and prescribing via a structured prescribing arrangement (<a href="./references#CD011227-bbs2-0186" title="Health Workforce Australia 2013. Health Professionals Prescribing Pathway (HPPP) Project ‐ Final Report. www.healthinfonet.ecu.edu.au/key‐resources/bibliography/?lid=26503 (accessed 12 February 2014). ">HWA 2013</a>). The reforms started by HWA have been transferred to a working group of the Australian Health Practitioner Regulation Agency. As part of the reform process, health agencies in Australia, Canada, New Zealand, and the UK have developed prescribing competency frameworks for non‐medical health professionals (<a href="./references#CD011227-bbs2-0196" title="National Prescribing Centre, National Institute for Health and Clinical Excellence. A single competency framework for all prescribers. www.associationforprescribers.org.uk/images/Single_Competency_Framework.pdf (accessed 30 October 2016). ">NPC 2012</a>; <a href="./references#CD011227-bbs2-0197" title="National Prescribing Service MedicineWise. NPS: Better choices, Better health. Competencies required to prescribe medicines: putting quality use of medicines into practice. www.nps.org.au/__data/assets/pdf_file/0004/149719/Prescribing_Competencies_Framework.pdf (accessed 12 December 2012). ">NPS 2012</a>; <a href="./references#CD011227-bbs2-0199" title="Pharmacy Council of New Zealand. Pharmacist Prescribers. www.pharmacycouncil.org.nz/cms_display.php?sn=225&amp;st=1&amp;pg=1863 (accessed 26 December 2013). ">Pharmacy Council NZ 2013</a>; <a href="./references#CD011227-bbs2-0210" title="YukselN , EberhartG , BungardTJ . Prescribing by pharmacists in Alberta. American Journal of Health‐System Pharmacy2008;65:2126‐32. ">Yuksel 2008</a>). </p> </section> <section id="CD011227-sec-0018"> <h3 class="title" id="CD011227-sec-0018">Description of the intervention</h3> <p>For the purpose of our review the term 'non‐medical prescribing' was used to cover prescribing of medicines by a broad range of healthcare providers other than medical doctors, prescribing in primary or secondary care. No limitation was set on the type of non‐medical healthcare provider undertaking prescribing. Frequently, non‐medical prescribing is done in collaboration or partnership with doctors, and within this practice there are different models of prescribing practice. However, for this review the non‐medical prescriber was required to have a high degree of autonomy in their prescribing practice. We excluded studies reporting prescribing practices requiring medical review, consultation, and approval requiring a medical signature on medication orders. Our review focused on prescribing, which as per our definition is much broader than issuing a prescription. </p> <p>The role of non‐medical prescribers in secondary care settings may involve supporting acute or chronic care by prescribing in a timely way medication on admission, discharge, or where there is a specialist need, e.g. total parenteral nutrition. Specialist outpatient clinics managed by non‐medical health professionals may exist in either the primary or secondary care setting, e.g. for the management of hypertension, lipids, diabetes, and pain. In primary care settings, prescribing may be undertaken for acute or chronic conditions by nurses or other healthcare providers caring for patients in their homes or through involvement with general practice teams, community health centres, mental health teams, or community pharmacies. </p> </section> <section id="CD011227-sec-0019"> <h3 class="title" id="CD011227-sec-0019">How the intervention might work</h3> <p>Non‐medical prescribing has developed as an accepted healthcare practice in a number of countries to improve access to healthcare, to better use the skills of doctors who can focus on more acute patient needs, to better use the skills of pharmacists, nurses and other health providers, to potentially reduce costs for achieving at least equivalent, if not better health outcomes for consumers, and to retain health workers by increasing job satisfaction (<a href="./references#CD011227-bbs2-0171" title="Department of Health. Review of prescribing, supply and administration of medicines (the Crown Report). webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4077153.pdf (accessed 3 November 2012). ">Department of Health 1999</a>; <a href="./references#CD011227-bbs2-0206" title="TonnaAP , StewartD , WestB , McCaigD . Pharmacist prescribing in the UK ‐ a literature review of current practice and research. Journal of Clinical Pharmacy and Therapeutics2007;32(6):545‐56. ">Tonna 2007</a>). While qualitative studies support non‐medical prescribing from a patient and practitioner perspective, robust evidence is still required for clinical, patient‐reported, and resource use outcomes. It is noted that where non‐medical prescribers are practising in collaborative teams, it may be difficult to apportion the impact of the non‐medical prescribing component to the primary and secondary outcomes of this review. Wider adoption of non‐medical prescribing practice in high‐income countries frequently faces local regulatory hurdles and opposition from the medical community which has raised concerns about professional autonomy, patient safety, the diagnostic competency of non‐medical prescribers, and costs (<a href="./references#CD011227-bbs2-0170" title="CooperR , GuillaumeL , AveryT , AndersonC , BissellP , HutchinsonA , et al. Nonmedical prescribing in the United Kingdom Development and stakeholder Interests. Journal of Ambulatory Care Management2008;31(3):244‐52. ">Cooper 2008</a>). Evidence that patient outcomes arising from non‐medical prescribing are as effective as those from medical prescribing would provide a basis for policy‐makers to support wider implementation of this practice. </p> </section> <section id="CD011227-sec-0020"> <h3 class="title" id="CD011227-sec-0020">Why it is important to do this review</h3> <p>It is important for health practitioners and policy‐makers to understand the evidence existing for non‐medical prescribing in order to address access or health workforce needs. This information will also guide future decision making with regards to implementing or expanding non‐medical prescribing. </p> <p>Potential beneficiaries of the findings include:</p> <p> <ol id="CD011227-list-0001"> <li> <p>policy‐makers seeking to use workforce resources more efficiently;</p> </li> <li> <p>policy‐makers seeking to meet a clinical need;</p> </li> <li> <p>consumers seeking greater choice and easier access to medicines;</p> </li> <li> <p>non‐medical health professionals seeking to better utilise their skills and/or extend their scope of practice; and </p> </li> <li> <p>medical staff seeking to focus on patients with the greatest medical need.</p> </li> </ol> </p> <p>Despite a gradual rolling out of reforms, the evidence for the potential benefits of non‐medical prescribing from well‐controlled trials involving a wide range of health professionals requires identification, synthesis, and evaluation. Several narrative reviews of the non‐medical prescribing literature have been undertaken (<a href="./references#CD011227-bbs2-0188" title="KayOC , BrienJE . Pharmacist prescribing: review of the literature. Journal of Pharmacy Practice and Research2004;34:300‐4. ">Kay 2004</a>; <a href="./references#CD011227-bbs2-0206" title="TonnaAP , StewartD , WestB , McCaigD . Pharmacist prescribing in the UK ‐ a literature review of current practice and research. Journal of Clinical Pharmacy and Therapeutics2007;32(6):545‐56. ">Tonna 2007</a>), and the British government commissioned two evaluations covering supplementary and independent prescribing (<a href="./references#CD011227-bbs2-0165" title="BissellP , CooperR , GuillaumeL , AndersonC , AveryA , HutchinsonA , et al. An evaluation of supplementary prescribing in nursing and pharmacy. Final report for the Department of Health. Research Report. University of Sheffield. www.shef.ac.uk/polopoly_fs/1.43225!/file/Supplementary_prescribing.pdf (accessed 3 November 2012). ">Bissell 2008</a>; <a href="./references#CD011227-bbs2-0189" title="LatterS , BlenkinsoppA , SmithA , ChapmanS , TinelliM , GerardK , et al. Evaluation of nurse and pharmacist independent prescribing. Department of Health Policy Research Programme Project 016 0108. University of Southampton; Keele University, on behalf of Department of Health. www.eprints.soton.ac.uk/184777/ (accessed 3 November 2012). ">Latter 2010</a>). </p> <p>A Cochrane Review on substitution of doctors by suitably trained nurses in primary care found that trained nurses can produce as high a quality of care and as good health outcomes with no appreciable difference between doctors and nurses in resource utilisation outcomes associated with prescribing (<a href="./references#CD011227-bbs2-0190" title="LaurantM , ReevesD , HermensR , BraspenningJ , GrolR , SibbaldB . Substitution of doctors by nurses in primary care. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD001271.pub2] ">Laurant 2005</a>). The review was limited to nurses in the primary care setting as first contact or ongoing care for undifferentiated patients.  </p> <p>A further Cochrane Review found a single RCT of pharmacist‐managed drug therapy (<a href="./references#CD011227-bbs2-0195" title="NkansahN , MostovetskyO , YuC , ChhengT , BeneyJ , BondCM , et al. Effect of outpatient pharmacists' non‐dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews2010, Issue 7. [DOI: 10.1002/14651858.CD000336.pub2] ">Nkansah 2010</a>), including the prescribing of drugs versus physician medication management (<a href="./references#CD011227-bbs2-0085" title="HawkinsDW , FiedlerFP , DouglasHL , EschbachRC . Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. American Journal of Hospital Pharmacy1979;36:1321‐5. ">Hawkins 1979</a>). However, we assessed the study to be of low‐quality, leaving open the question of whether the delivery of patient‐targeted services by pharmacists improves patient outcomes compared to other health professionals. </p> <p>The <a href="./references#CD011227-bbs2-0174" title="DriscollA , CurreyJ , TonkinA , KrumH . Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD009889.pub2] ">Driscoll 2015</a> Cochrane Review of nurse‐led titration of drug therapy for people with heart failure, found that participants in the nurse‐led group were less likely to be admitted to hospital or to die. More participants reached the maximum drug dose in the nurse‐led titration group compared to titration of doses by primary care physicians. The certainty of evidence that nurse‐led titration reduced hospitalisations was graded as high and the certainty of evidence regarding the proportion of participants reaching optimal dose was graded as low. However, in the majority of studies the influence of medical supervision on nurse‐dose titration (prescribing) was unclear. </p> <p>Against this background, we systematically identified, reviewed, and updated the evidence from controlled studies and uncontrolled studies on the clinical, patient‐reported and resource use outcomes of non‐medical prescribing in primary and secondary care settings. This review considered any adverse effects of non‐medical prescribing which may be clinical (e.g. deterioration in care or incidence of adverse drugs reactions), patient‐reported (e.g. decreased satisfaction), or resource‐related (e.g. increased treatment costs). </p> <p>The review covered healthcare providers undertaking non‐medical prescribing, spanning primary and secondary care settings, and considered acute and chronic prescribing situations. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011227-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011227-sec-0021"></div> <p>To assess the clinical, patient‐reported, and resource use outcomes of non‐medical prescribing for managing acute and chronic health conditions in primary and secondary care settings compared with medical prescribing (usual care). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011227-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011227-sec-0022"></div> <section id="CD011227-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011227-sec-0024"> <h4 class="title">Types of studies</h4> <p>We included studies of patients or health professionals or healthcare settings using the definitions of designs outlined in the Cochrane Effective Practice and Organisation of Care (EPOC) Group checklist (<a href="./references#CD011227-bbs2-0167" title="Cochrane Effective Practice and Organisation of Care Group. Cochrane Effective Practice and Organisation of Care (EPOC). Data collection form. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/13%20Data%20extraction%20and%20management%202013%2008%2012_1.pdf (accessed prior to 21 September 2016). ">Cochrane EPOC Group 2013a</a>). We included randomised controlled trials (RCTs) and cluster‐RCTs, one controlled trial where investigators had allocated participants to the different groups that were being compared using a method that is not random, but where at least two groups with interventions were followed, and one controlled before‐and‐after (CBA) study with at least two intervention sites and two control sites. We did not find either interrupted time series (ITS) studies nor qualitative studies linked to quantitative studies using qualitative analysis methods. </p> </section> <section id="CD011227-sec-0025"> <h4 class="title">Types of participants</h4> <p>Healthcare providers who are not medical doctors, undertaking prescribing including, nurses, optometrists, pharmacists, physician assistants, and other allied health professionals or categories not specifically mentioned whose roles meet our definition of non‐medical prescribing. </p> <section id="CD011227-sec-0026"> <h5 class="title">Setting</h5> <p>We included studies based in any primary or secondary care setting where non‐medical prescribing occurred. </p> </section> </section> <section id="CD011227-sec-0027"> <h4 class="title">Types of interventions</h4> <p>We included studies involving health providers other than medical doctors undertaking prescribing according to our definition of prescribing. We excluded studies limited to the supply function of pharmacists, including over‐the‐counter products and studies involving the supply function of lay health workers. </p> <p>We included the following six comparisons for non‐medical prescribing.</p> <p> <ol id="CD011227-list-0002"> <li> <p>Non‐medical prescribing versus medical prescribing in acute care.</p> </li> <li> <p>Non‐medical prescribing versus medical prescribing in chronic care.</p> </li> <li> <p>Non‐medical prescribing versus medical prescribing in secondary care.</p> </li> <li> <p>Non‐medical prescribing versus medical prescribing in primary care.</p> </li> <li> <p>Comparisons between different non‐medical prescriber groups.</p> </li> <li> <p>Non‐medical healthcare providers with formal prescribing training versus those without formal prescribing training. </p> </li> </ol> </p> </section> <section id="CD011227-sec-0028"> <h4 class="title">Types of outcome measures</h4> <p>The studies included in the review reported a wide variety of outcome measures. We only included studies with objective measures of patient clinical outcomes. Non‐inferiority was regarded as a positive outcome where a non‐medical prescribing outcome was at least as good as the comparator. We excluded studies with only a qualitative component in order to maintain the clinical focus of the review. </p> <section id="CD011227-sec-0029"> <h5 class="title">Primary outcomes</h5> <section id="CD011227-sec-0030"> <h6 class="title">Clinical outcomes</h6> <section id="CD011227-sec-0031"> <p><b>Patient outcomes</b></p> <p>We used standard outcome measures covering health and well‐being, including physiological measures of treatment such as systolic blood pressure, glycated haemoglobin, and low‐density lipoprotein. Outcomes were divided into dichotomous and continuous outcomes. </p> <p>We also considered the following outcomes.</p> <p> <ol id="CD011227-list-0003"> <li> <p>Proportion of prescribers, medical and non‐medical, appropriately adhering to practice guidelines. </p> </li> <li> <p>Proportion of patients demonstrating medication adherence.</p> </li> <li> <p>Proportion of patients and items appropriately prescribed or deprescribed.</p> </li> <li> <p>Patient satisfaction, where measured by a validated tool as part of an effectiveness study. </p> </li> <li> <p>Non‐medical prescriber versus medical prescriber waiting time to care.</p> </li> <li> <p>Non‐medical prescribers adversely affecting the health outcomes of patients through medication errors, prescribing errors, adverse events, wrong diagnoses or treatment, increased hospitalisations, or representations for medical care. </p> </li> </ol> </p> </section> </section> </section> <section id="CD011227-sec-0032"> <h5 class="title">Secondary outcomes</h5> <section id="CD011227-sec-0033"> <h6 class="title">Patient‐reported outcomes</h6> <p>We considered patient‐reported outcomes without clinician interpretation of their knowledge requirements, daily functioning, and health‐related quality of life. </p> </section> <section id="CD011227-sec-0034"> <h6 class="title">Non‐medical prescriber outcomes</h6> <p>Where present, we also reported non‐medical prescriber outcomes of job satisfaction, skills utilisation, education needs, and workload effects. </p> </section> <section id="CD011227-sec-0035"> <h6 class="title">Resource use outcomes</h6> <p> <ol id="CD011227-list-0004"> <li> <p>Medical time saved by non‐medical prescribers.</p> </li> <li> <p>Non‐medical prescriber versus medical prescriber prescription volume and cost, patient out‐of‐pocket expenses, service costs, and deprescribing rate and cost. </p> </li> <li> <p>Increased resource use for providing the intervention and for providing subsequent care such as hospitalisations, emergency department visits, and outpatient visits. </p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD011227-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011227-sec-0037"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases.</p> <p> <ol id="CD011227-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, including the Effective Practice and Organisation of Care (EPOC) Group Specialised Register; 2016, Issue 6), in the Cochrane Library (Wiley). </p> </li> <li> <p>Cochrane Methodology Register, the Cochrane Library; 2012, Issue 3 (Wiley).</p> </li> <li> <p><i>Cochrane Database of Systematic Reviews</i> (CDSR), the Cochrane Library; 2016, Issue 7. </p> </li> <li> <p>Database of Abstracts and Reviews of Effects (DARE), the Cochrane Library; 2015, Issue 2 (Wiley). </p> </li> <li> <p>Health Technology Assessment Database, the Cochrane Library; 2016, Issue 2 (Wiley).</p> </li> <li> <p>NHS Economic Evaluation Database, the Cochrane Library; 2015, Issue 2 (Wiley).</p> </li> <li> <p>MEDLINE (1946 to 19 July 2016), (Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to 19 July 2016) (OvidSP). </p> </li> <li> <p>Embase (OvidSP) (1980 to 18 July 2016).</p> </li> <li> <p>PsycINFO (OVID) (1806 to July Week 2, 2016).</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCOhost) (1980 to 19 July 2016). </p> </li> </ol> </p> <p>The MEDLINE search strategy as illustrated in <a href="./appendices#CD011227-sec-0125">Appendix 1</a> was developed by the Cochrane Effective Practice and Organisation of Care (EPOC) Group Information Specialist in consultation with the authors. We translated it for other databases using appropriate syntax and vocabulary for those databases. We employed the Cochrane Highly Sensitive Search Strategy (sensitivity‐ and precision‐maximizing version, 2008 revision) to identify randomised trials, and the Cochrane EPOC Group methodology filter to identify non‐randomised studies. We managed search results using reference management software and removed duplicates before screening was undertaken. We also searched the <i>Cochrane Database of Systematic Reviews</i> (CDSR) and the Database of Abstracts of Reviews of Effects (DARE) for related systematic reviews. </p> </section> <section id="CD011227-sec-0038"> <h4 class="title">Searching other resources</h4> <section id="CD011227-sec-0039"> <h5 class="title">Grey literature</h5> <p>We conducted a grey literature search to identify studies not indexed in the databases listed above. We used the following sources. </p> <p> <ol id="CD011227-list-0006"> <li> <p>OpenGrey (<a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu</a>). </p> </li> <li> <p>Grey Literature Report by the New York Academy of Medicine (<a href="http://www.greylit.org/" target="_blank">www.greylit.org</a>). </p> </li> <li> <p>Agency for Healthcare Research and Quality (AHRQ) (<a href="http://www.ahrq.gov/" target="_blank">www.ahrq.gov</a>). </p> </li> </ol> </p> </section> <section id="CD011227-sec-0040"> <h5 class="title">Trial registries</h5> <p>We searched the following registries.</p> <p> <ol id="CD011227-list-0007"> <li> <p>The Word Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>). </p> </li> </ol> </p> <p>The corresponding search terms and numbers of results are reported.</p> </section> <section id="CD011227-sec-0041"> <h5 class="title">Other resources</h5> <p> <ol id="CD011227-list-0008"> <li> <p>We screened individual journals and conference proceedings (via handsearching).</p> </li> <li> <p>We reviewed reference lists of all included studies, relevant systematic reviews; reference lists of other publications. </p> </li> <li> <p>We contacted authors of relevant studies or reviews when necessary to clarify reported published information or to seek unpublished results or data. </p> </li> <li> <p>We contacted researchers with expertise relevant to the review topic/EPOC interventions.</p> </li> <li> <p>We conducted cited reference searches for all included studies in citations indices.</p> </li> </ol> </p> </section> </section> </section> <section id="CD011227-sec-0042"> <h3 class="title" id="CD011227-sec-0042">Data collection and analysis</h3> <section id="CD011227-sec-0043"> <h4 class="title">Selection of studies</h4> <p>We merged the search results through the use of a reference management software and removed duplicate records. Two review authors (GW, JG) then independently assessed the titles and abstracts of the search results to evaluate their potential eligibility, and discussed the relevance of articles to the topic. The two review authors were not responsible for the selection of studies they were involved in or associated with. Neutral members of the review team were responsible for assessing the eligibility of each study for inclusion in the review. We retrieved the full‐text of all remaining relevant papers and the two review authors assessed these full‐text articles independently, based on the review's inclusion criteria. </p> <p>We included a '<a href="./references#CD011227-sec-0140" title="">Characteristics of excluded studies</a>' table in the review. This table included studies that appear to meet the inclusion criteria but were eventually excluded, and we reported the reasons for exclusion (e.g. not a RCT, only one intervention and/or control site for a CBA study, absence of non‐medical prescriber autonomy). If there was uncertainty or disagreement, consensus was reached by discussion with other review authors. We corresponded with authors of included studies if necessary to obtain further information in order to assess compliance with eligibility and confirm data. Within the review, we mapped the flow of information of identified, included, and excluded studies by depicting them in a PRISMA flow diagram (<a href="./references#CD011227-bbs2-0194" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA Statement. BMJ2009;339:2535. ">Moher 2009</a>) (<a href="#CD011227-fig-0001">Figure 1</a>).  </p> <div class="figure" id="CD011227-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011227-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011227-sec-0044"> <h4 class="title">Data extraction and management</h4> <p>We adapted a standard data extraction form based on the Cochrane EPOC Group's data collection checklist (<a href="./references#CD011227-bbs2-0167" title="Cochrane Effective Practice and Organisation of Care Group. Cochrane Effective Practice and Organisation of Care (EPOC). Data collection form. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/13%20Data%20extraction%20and%20management%202013%2008%2012_1.pdf (accessed prior to 21 September 2016). ">Cochrane EPOC Group 2013a</a>). We designed and assessed the form to suitably extract data on the characteristics of each study, including study design, study participants, the interventions and comparators, outcomes and follow‐up periods, funding source, and interest declarations. Four review authors (GW, JG, DS, KM) independently extracted study characteristics and the outcome data outlined above. We checked the data against each other. If there was uncertainty or disagreement, we reached consensus by discussion or in the presence of an adjudicating third review author, if necessary. We contacted study authors to obtain any missing information. If a study was reported in more than one publication, we extracted the data from all publications into separate data collection forms before combining them. </p> </section> <section id="CD011227-sec-0045"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (GW, JG) independently assessed the risk of bias of included studies, with any disagreements resolved by consensus with a third review author (KM). We used the Cochrane EPOC Group nine‐point criteria for RCTs, non‐RCTs, and CBA studies (<a href="./references#CD011227-bbs2-0169" title="Cochrane Effective Practice and Organisation of Care Group. Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2015. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/14%20Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews%202015%2009%2002.pdf (accessed prior to 21 September 2016). ">Cochrane EPOC Group 2015</a>). </p> <p> <ol id="CD011227-list-0009"> <li> <p>Allocation sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Baseline outcome measurements.</p> </li> <li> <p>Baseline characteristics.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Knowledge of allocated interventions.</p> </li> <li> <p>Protection against contamination.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other risks of bias.</p> </li> </ol> </p> <p>We did not find any ITS studies, but we will assess future studies using the seven standard Cochrane EPOC Group criteria for ITS studies (<a href="./references#CD011227-bbs2-0169" title="Cochrane Effective Practice and Organisation of Care Group. Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2015. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/14%20Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews%202015%2009%2002.pdf (accessed prior to 21 September 2016). ">Cochrane EPOC Group 2015</a>). </p> <p> <ol id="CD011227-list-0010"> <li> <p>Intervention independent of other changes.</p> </li> <li> <p>Prespecified effect shape.</p> </li> <li> <p>Intervention unlikely to affect data collection.</p> </li> <li> <p>Blinding.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ol> </p> <p>We rated each component and categorised it in a 'Risk of bias' table as 'low risk', 'unclear risk', or 'high risk', as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011227-bbs2-0183" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We documented for each included study a summary assessment of the risk of bias. </p> </section> <section id="CD011227-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <p>We recorded and reported measures of effect in the same way investigators reported them. We performed all analyses using Cochrane's statistical software, Review Manager 5 (<a href="./references#CD011227-bbs2-0201" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and recorded data in the form of a table included in the Cochrane EPOC Group's data extraction template (<a href="./references#CD011227-bbs2-0168" title="Cochrane Effective Practice and Organisation of Care Group. Effective Practice and Organisation of Care (EPOC). Data extraction and management. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/13%20Data%20extraction%20and%20management%202013%2008%2012_1.pdf (accessed prior to 21 September 2016). ">Cochrane EPOC Group 2013b</a>). For continuous variables, we reported mean differences (MDs) with 95% confidence intervals (CIs) between the intervention and comparison groups. We used a standardised mean difference (SMD) with 95% CI for the same continuous variable measured with different scales. For dichotomous outcomes, we calculated the risk difference (RD) with 95% CI. We planned to calculate the risk ratio (RR), again with 95% CI. </p> </section> <section id="CD011227-sec-0047"> <h4 class="title">Unit of analysis issues</h4> <p>We assessed whether an appropriate adjustment had been made for clustering in RCTs and CBA studies to avoid unit of analysis errors. If there were insufficient data for re‐analysis, we attempted to correct such errors by contacting study authors to obtain additional data. Determining the intracluster correlation coefficient from additional data or like studies allows adjustment of clustering by inflating the standard error. Where re‐analysis was not possible we reported the point estimate without a standard error or CI and the P value was annotated 're‐analysed'. </p> </section> <section id="CD011227-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>We applied the 'Risk of bias' criteria to exclude studies with a high risk of missing data, as they pose serious threats to validity (<a href="./references#CD011227-bbs2-0183" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). Where appropriate, we contacted study authors for further information. If this was not possible, we reported the number of participants lost to follow‐up. Imputing missing data was only considered when continuous outcomes were reported without measures of variance. We followed the principles of intention‐to‐treat analysis as far as possible. </p> </section> <section id="CD011227-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>We found that the range of healthcare settings, differing non‐medical prescribers, differing clinical conditions being managed, and variation in study designs lead to clinical, methodological, and statistical heterogeneity. Assessment of these differences informed the analysis and determined whether results could be statistically combined in a meta‐analysis. The review team made this decision on a consensus basis. We assessed statistical heterogeneity by using the Chi<sup>2</sup> test to assess if differences in results are compatible with chance alone using P &lt; 0.10. We quantified statistical heterogeneity using the I<sup>2</sup> statistic, as appropriate. We determined that heterogeneity might not be important between 0% and 40%, 30% to 60% represented moderate heterogeneity, 50% to 90% substantial heterogeneity, and 75% to 100% considerable heterogeneity (<a href="./references#CD011227-bbs2-0183" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD011227-sec-0050"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed the risk of publication bias based on the information in the 'Risk of bias' tables and constructed funnel plots for the outcomes of systolic blood pressure and low‐density lipoprotein. </p> </section> <section id="CD011227-sec-0051"> <h4 class="title">Data synthesis</h4> <p>We used a structured synthesis approach to analyses. After consideration of the small‐study effects of many included studies we used a fixed‐effect model for meta‐analysis and compared outcomes with a random‐effects model. For quantitative synthesis we used Review Manager 5 for statistical analysis (<a href="./references#CD011227-bbs2-0201" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Where we could not combine data for a meta‐analysis due to inconsistency of reporting measures, or when it was not applicable to use the average effect across studies of an intervention, we reported in this plain language summaries as appropriate. We included key data elements such as explanatory factors, results, effects, and certainty of evidence in a table for each category of interventions. </p> <section id="CD011227-sec-0052"> <h5 class="title">Summary of findings</h5> <p>We used a 'Summary of findings' table and GRADEpro GDT software to record results, outcomes, and outcome risks in our structured synthesis (<a href="./references#CD011227-bbs2-0180" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 1 August 2015. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro GDT 2014</a>). In addition, we used the five GRADE study considerations (study limitations, consistency of effort, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence and summarise our confidence in the effects of the interventions by outcome across studies (<a href="./references#CD011227-bbs2-0163" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpY , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">Atkins 2004</a>). We included the following outcomes in the 'Summary of findings' table: systolic blood pressure, glycated haemoglobin, low‐density lipoprotein, medication adherence, patient satisfaction, adverse events, and health‐related quality of life. We justified all decisions to down‐ or upgrade the certainty of evidence using footnotes, and we made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> <section id="CD011227-sec-0053"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Differences in healthcare settings, non‐medical prescriber types, clinical conditions being managed, and study designs informed the assessments of methodological and statistical heterogeneity. </p> <p>Explanatory variables or effect modifiers which may have influenced the size of intervention effects included the level of prescriber education, study location, patient condition being treated, and adherence to therapy and practice guidelines. The degree of non‐medical prescribing autonomy within and across subgroups may have explained differences in outcomes and limited the applicability of findings. </p> <p>For consistency across studies, we presented data as subgroups for the clinical outcomes of systolic blood pressure, glycated haemoglobin, and low‐density lipoprotein at six and 12 months. We presented quality of life measures (SF‐36 and SF‐12) as subgroups of physical component and mental component scores. </p> <p>In considering the type of intervention, we did not undertake a meta‐analysis comparing algorithm prescribing to more autonomous prescribing on clinical outcomes due to considerable heterogeneity. </p> <p>There were insufficient studies to compare outcomes from different non‐medical prescriber settings e.g. secondary care versus primary care. </p> <p>Variability in education standards made it difficult to compare non‐medical prescriber subgroups. </p> </section> <section id="CD011227-sec-0054"> <h4 class="title">Sensitivity analysis</h4> <p>We undertook a sensitivity analysis comparing meta‐analyses outcomes using fixed‐effect and random‐effects analyses for the three clinical surrogate markers of disease: systolic blood pressure; glycated haemoglobin; and low‐density lipoprotein (<a href="#CD011227-tbl-0002">Table 1</a>). The effect modifier of clustering in RCTs on systolic blood pressure at six months was tested by removing these trials from the meta‐analysis (<a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> at six months; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a> and <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> at 12 months; <a href="./references#CD011227-fig-0007" title="">Analysis 1.2</a>; <a href="./references#CD011227-fig-0008" title="">Analysis 1.3</a>). We did not undertake a sensitivity analysis excluding unclear or high risk of bias studies due to the similar risk of bias elements existing within the outcome categories. </p> <div class="table" id="CD011227-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Fixed‐effect outcomes versus random‐effects for clinical surrogate markers</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome or subgroup</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed‐effect estimate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random‐effects estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 Systolic blood pressure (mmHg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.85 (‐6.76 to ‐4.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.59 (‐8.48 to ‐4.71)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.76 (‐8.24 to ‐5.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐7.34 (‐11.09 to ‐3.60)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.31 (‐6.46 to ‐4.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.91 (‐7.71 to ‐4.10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 HbA1c (%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.55 (‐0.74 to ‐0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.55 (‐0.76 to ‐0.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2.1 HbA1c (6 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.42 (‐0.75 to ‐0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.45 (‐0.09 to ‐0.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2.2 HbA1c (12 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.62 (‐0.85 to ‐0.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.62 (‐0.85 to ‐0.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3 LDL (mmol/L)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.23 (‐0.28 to ‐0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.22 (‐0.42 to ‐0.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3.1 LDL (6 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.25 (‐0.34 to ‐0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.13 (‐0.39 to 0.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3.2 LDL (12 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.21 (‐0.29 to ‐0.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.3 (‐0.62 to 0.02)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>LDL: low‐density lipoprotein</p> </div> </div> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011227-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011227-sec-0055"></div> <section id="CD011227-sec-0056"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD011227-sec-0139" title="">Characteristics of included studies</a>; <a href="./references#CD011227-sec-0140" title="">Characteristics of excluded studies</a>; <a href="./references#CD011227-sec-0141" title="">Characteristics of studies awaiting classification</a>; <a href="./references#CD011227-sec-0142" title="">Characteristics of ongoing studies</a>. </p> <section id="CD011227-sec-0057"> <h4 class="title">Results of the search</h4> <p>The database search yielded 13,220 titles. We found 51 additional studies through handsearching. After removing duplicates, we screened 9335 studies and reviewed 162 full‐text articles. We excluded 112 studies that did not meet the inclusion criteria and recorded our reasons for exclusion. We included 46 studies (37,337 participants). Of these, 44 were randomised controlled trials (RCTs), including six cluster‐RCTs (<a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>; <a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a>; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>; <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>), one controlled trial (<a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a>), and one controlled before‐and‐after (CBA) study (<a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). Three studies are awaiting classification (<a href="./references#CD011227-bbs2-0159" title="BartonGR , FairallL , BachmannMO , UebelK , TimmermanV , LombardC , et al. Cost‐effectiveness of nurse‐led versus doctor‐led antiretroviral treatment in South Africa: pragmatic cluster randomised trial. Tropical Medicine and International Health2013;18(6):769‐77. ">Barton 2013</a>; <a href="./references#CD011227-bbs2-0160" title="NeilsonAR , BruhnH , BondCM , ElliottAM , SmithBH , HannafordPC , et al. Pharmacist‐led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial. BML Open2015;5:e006874. [DOI: 10.1136/bmjopen‐2014‐006874] ">Neilson 2015</a>; <a href="./references#CD011227-bbs2-0161" title="TsuyukiRT , RosenthalMM , PearsonGJ . Improving dyslipidemia management in the community: A randomized trial of pharmacist prescribing, The RxACT study. Canadian Journal of Cardiology2014;30(10):S118‐9. ">Tsuyuki 2014</a>), and one study is ongoing (<a href="./references#CD011227-bbs2-0162" title="MikulsTR , CheethamTC , RashidN , LevyGD , KerimianA , LowKJ , et al. A pragmatic cluster‐randomized controlled trial of an automated, pharmacy‐based intervention to optimize allopurinol therapy in gout. Arthritis and Rheumatology2015;67:Suppl 10. ">Mikuls 2015</a>). Refer to <a href="#CD011227-fig-0001">Figure 1</a> for PRISMA diagram. </p> </section> <section id="CD011227-sec-0058"> <h4 class="title">Included studies</h4> <p>Non‐medical prescribing studies were included where the health professional (other than a medical practitioner) undertook a high level of autonomous prescribing. This included medication initiation, dosage change, or cessation of medication (with or without guidance from established protocols and guidelines). </p> <section id="CD011227-sec-0059"> <h5 class="title">Participants</h5> <p>Non‐medical prescribing versus medical prescribing was practised by nurses in 26 studies with 28,621 participants (<a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a>; <a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a>; <a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0004" title="BeckerDM , YanekLR , JohnsonWR , GarrettD , MoyTF , ReynoldsSS , et al. Impact of a community‐based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation2005;111:1298‐304. ">Becker 2005</a>; <a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a>; <a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a>; <a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a>; <a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>; <a href="./references#CD011227-bbs2-0015" title="FischerHH , EisertSL , EverhartRM , DurfeeMJ , MooreSL , SoriaS , et al. Nurse‐run, telephone‐based outreach to improve lipids in people with diabetes. American Journal of Managed Care2012;18(2):77‐84. ">Fischer 2012</a>; <a href="./references#CD011227-bbs2-0017" title="HillMN , HanHR , DennisonCR , KimMT , RoaryMC , BlumenthalRS , et al. Hypertension care and control in undeserved urban African American men: Behavioural and physiological outcomes at 36 months. American Journal of Hypertension2003;16:906‐13. ">Hill 2003</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a>; <a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a>; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>; <a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a>; <a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a>; <a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>; <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>; <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a>; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>; <a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>; <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>; <a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a>; <a href="./references#CD011227-bbs2-0042" title="TobeS , PylypchukG , WentworthJ , KissA , SzalaiJP , PerkinsN , et al. Effect of nurse‐directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomised controlled trial. Canadian Medical Association Journal2006;174(9):1267‐71. ">Tobe 2006</a>; <a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a>), and by pharmacists in 20 studies with 8716 participants (<a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>; <a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a>; <a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0012" title="EllisSL , CarterBL , MaloneDC , BillupsSJ , OkanoGJ , ValuckRJ , et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy2000;20(12):1508‐16. ">Ellis 2000</a>; <a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>; <a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a>; <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a>; <a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>; <a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>; <a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a>; <a href="./references#CD011227-bbs2-0044" title="TsuyukiRT , Al HamarnehYN , JonesCA , HemmelgarnBR . The effectiveness of pharmacist interventions on cardiovascular risk. The multicenter randomized controlled RxEACH trial. Journal of the American College of Cardiology2016;67(24):2846‐54. ">Tsuyuki 2016</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>). </p> <p>The health professionals delivering the interventions were pharmacists or nurses with varying degrees of formal or informal training. We did not find any studies where other non‐medical health professionals, such as physician assistants undertook prescribing roles. Nurse prescribing was undertaken in the majority of studies by reference to algorithms. While nurses exercised independence in prescribing by algorithm, physicians were usually available for consultation for issues beyond the scope of the algorithm, or for more complex cases or for periodic review. </p> <p>Pharmacist prescribing was generally undertaken in a more autonomous way, with more reliance on clinical judgement and guidelines rather than restrictive algorithms. This broader practice scope was supported through collaborative practice agreements in the USA and independent or supplementary prescribing in the UK. In addition to their defined prescribing autonomy, non‐medical prescribers in several studies had limits placed on additional prescribing, and required medical prescribing or approval for dose acceleration (<a href="./references#CD011227-bbs2-0042" title="TobeS , PylypchukG , WentworthJ , KissA , SzalaiJP , PerkinsN , et al. Effect of nurse‐directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomised controlled trial. Canadian Medical Association Journal2006;174(9):1267‐71. ">Tobe 2006</a>), management of conditions outside the focus of care (<a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>; <a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>; <a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>), and initiation of new drugs (<a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a>; <a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>). </p> <p>Excluding the cluster‐RCTs, nine studies had less than 100 patients, seven studies had more than 100 and less than 200 patients, 16 studies had more than 200 and less than 500 patients, five studies had between 500 to 800 patients, and three studies included over 1000 patients. There were six cluster‐RCTs: <a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>, 31 clinics, cohort one 9252 patients, cohort two 6231 patients; <a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a>, 16 primary care teams at five medical centres, 4100 patients; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>, 20 primary care practices, 1316 patients; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>, 16 primary care clinics, 450 patients; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>, 21 general practices, 1906 patients; <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>, 18 nurse‐led health centres, 3960 patients. </p> </section> <section id="CD011227-sec-0060"> <h5 class="title">Setting</h5> <p>Four nurse prescribing studies (14,921 participants) were undertaken in low‐ and middle‐income settings within Colombia, South Africa, Uganda, and Thailand (<a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a>; <a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>; <a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a>; <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>). The remainder of studies were undertaken in the high‐income countries, of Australia (1), Canada (6), Ireland (1), Netherlands (3), UK (6), and USA (25). Forty‐two studies were based in ambulatory care settings, including primary care clinics, medical centres, general practices, community pharmacies, and hospital outpatient clinics. Two studies were located in secondary care settings (<a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a>). One study was set in the workplace (<a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>), and one in an aged care setting (<a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). </p> </section> <section id="CD011227-sec-0061"> <h5 class="title">Interventions</h5> <p>Pharmacist and nurse interventions were often multifaceted, with prescribing being one element of a complex management approach. For example, in diabetes care, patient education, self‐care, diet, exercise, and follow‐up were factors influencing outcomes, as well as the prescribing of medications. </p> </section> <section id="CD011227-sec-0062"> <h5 class="title">Outcomes</h5> <p>The majority of studies involved the management of one or more chronic diseases (heart failure, hypertension, diabetes, dyslipidaemias) and risk factors for disease recurrence such as stroke (<a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>), and acute myocardial infarction or heart failure (<a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a>; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>). Studies outside of these areas included the management of chronic pain (<a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>), family planning (<a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a>), HIV treatment (<a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>), incomplete abortion (<a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a>), depression (<a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>), and asthma in children, which was the only paediatric study (<a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a>). </p> <p>Non‐medical clinician collaborative care approaches with physicians (<a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>), or community health workers (<a href="./references#CD011227-bbs2-0004" title="BeckerDM , YanekLR , JohnsonWR , GarrettD , MoyTF , ReynoldsSS , et al. Impact of a community‐based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation2005;111:1298‐304. ">Becker 2005</a>; <a href="./references#CD011227-bbs2-0017" title="HillMN , HanHR , DennisonCR , KimMT , RoaryMC , BlumenthalRS , et al. Hypertension care and control in undeserved urban African American men: Behavioural and physiological outcomes at 36 months. American Journal of Hypertension2003;16:906‐13. ">Hill 2003</a>), and interventions with telemonitoring (<a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>), added to the complexity of determining specific non‐medical prescribing outcomes. </p> <p>The following 21 studies had a more direct relationship between non‐medical prescribing and the outcome markers of the disease or condition: <a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> (heart failure); <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> (chronic pain); <a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> (anticoagulation); <a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a> (blood pressure); <a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> (HIV medications); <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> (blood pressure); <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> and <a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> (glycaemia, blood pressure, lipids); <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> (blood pressure); <a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> (glycaemia, blood pressure, lipids); <a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> (glycaemia, blood pressure, lipids); <a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a> (incomplete abortion); <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> (blood pressure); <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a> (glycaemia, blood pressure, lipids); <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> (blood pressure, lipids); <a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a> (regular medications); <a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> (medications in the geriatric setting); <a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a> (blood pressure); <a href="./references#CD011227-bbs2-0044" title="TsuyukiRT , Al HamarnehYN , JonesCA , HemmelgarnBR . The effectiveness of pharmacist interventions on cardiovascular risk. The multicenter randomized controlled RxEACH trial. Journal of the American College of Cardiology2016;67(24):2846‐54. ">Tsuyuki 2016</a> (glycaemia, blood pressure, lipids); <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> (blood pressure); and <a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a> (glycaemia, blood pressure, lipids). </p> </section> </section> <section id="CD011227-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded studies if the study design did not meet the EPOC criteria for a RCT, controlled clinical trial, CBA or ITS. We excluded studies where we judged that the non‐medical health professional did not have a significant degree of autonomy in their prescribing practice, and prescribing required medical review, consultation, or authorisation. </p> </section> </section> <section id="CD011227-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias assessment for included studies is presented in the 'Risk of bias' tables, under each study in the section <a href="./references#CD011227-sec-0139" title="">Characteristics of included studies</a>. The risk of bias results are presented in a graphical form in <a href="#CD011227-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD011227-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011227-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011227-sec-0065"> <h4 class="title">Allocation</h4> <p>Thirty‐three of 46 studies (72%) adequately described the random sequence generation and we considered them to be at low risk of bias. Allocation concealment was undertaken in 13 studies (28%), unclear in 31 studies (67%) and with no concealment in two studies (<a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). </p> </section> <section id="CD011227-sec-0066"> <h4 class="title">Blinding</h4> <p>Blinding of both participants and personnel could not be achieved through the study design in 44 of the 46 included studies. In the <a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> study it was unclear whether patients would be aware that the pharmacist had undertaken anticoagulation dose determinations, and in the <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a> study, whether the intervention group nurses had undertaken additional training and were using guidelines. Objective clinical outcomes in studies requiring laboratory measures such as glycated haemoglobin and low‐density lipoprotein were coded as blinded outcome assessment. In seven studies, blinded assessment of blood pressure was undertaken (<a href="./references#CD011227-bbs2-0017" title="HillMN , HanHR , DennisonCR , KimMT , RoaryMC , BlumenthalRS , et al. Hypertension care and control in undeserved urban African American men: Behavioural and physiological outcomes at 36 months. American Journal of Hypertension2003;16:906‐13. ">Hill 2003</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>; <a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>). Where blood pressure assessment was not clear or undertaken by study investigators, we judged this to be an unclear outcome assessment. <a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> used an independent research assistant to assess β‐blocker use in heart failure. </p> </section> <section id="CD011227-sec-0067"> <h4 class="title">Incomplete outcome data</h4> <p>Loss to follow‐up of 20% or more in either the intervention or control arms occurred in 14 studies (<a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a>; <a href="./references#CD011227-bbs2-0004" title="BeckerDM , YanekLR , JohnsonWR , GarrettD , MoyTF , ReynoldsSS , et al. Impact of a community‐based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation2005;111:1298‐304. ">Becker 2005</a>; <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>; <a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a>; <a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a>; <a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>; <a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a>; <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a>; <a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>; <a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>). </p> </section> <section id="CD011227-sec-0068"> <h4 class="title">Selective reporting</h4> <p>The funnel plots of systolic blood pressure revealed a degree of asymmetry, demonstrating a possible publication bias from an absence of published negative intervention studies. The funnel plot of low‐density lipoprotein studies was asymmetrical, with heterogeneity a consideration. </p> </section> <section id="CD011227-sec-0069"> <h4 class="title">Other potential sources of bias</h4> <p>The majority of studies had a degree of confounding either by the multifactorial intervention (which made it difficult to distinguish the influence of non‐medical prescribing on outcomes) or by unclear prescribing autonomy or medical influence. The six cluster‐RCTs appropriately accounted for the cluster design. </p> </section> </section> <section id="CD011227-sec-0070"> <h3 class="title" id="CD011227-sec-0070">Effects of interventions</h3> <p>See: <a href="./full#CD011227-tbl-0001"><b>Summary of findings for the main comparison</b> Non‐medical prescribing compared to medical prescribing for acute and chronic disease management in primary and secondary care</a> </p> <p>See: <a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a> for the main comparisons; systolic blood pressure, glycated haemoglobin, low‐density lipoprotein, adherence, adverse events, patient satisfaction, and quality of life. </p> <p>We had planned to analyse the six comparisons listed in the <a href="#CD011227-sec-0027">Types of interventions</a> section, however we only found studies for the following two comparisons: non‐medical prescribing in acute care (secondary care); and non‐medical prescribing in chronic care (primary/ambulatory care). </p> <section id="CD011227-sec-0071"> <h4 class="title">Non‐medical prescribing in acute care (secondary care)</h4> <section id="CD011227-sec-0072"> <h5 class="title">Primary Outcomes</h5> <p>Studies involving non‐medical prescribing interventions were often characterised by degrees of confounding, including the presence of multiple interventions, patient comorbidities, study duration, differing levels of non‐medical prescriber training, and unclear influences from medical prescribers. However, while recognising these complexities and limitations, care involving non‐medical prescribers resulted in improvements or similar effectiveness to usual care for a range of clinical outcomes and surrogate disease markers. </p> <p>We found two studies (438 participants) where non‐medical prescribing was practised in an acute/secondary care setting (<a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a>). </p> <section id="CD011227-sec-0073"> <h6 class="title">1. Systolic blood pressure</h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0074"> <h6 class="title">2. Glycated haemoglobin</h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0075"> <h6 class="title">3. Low‐density lipoprotein</h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0076"> <h6 class="title">4. Proportion of prescribers, medical and non‐medical, appropriately adhering to practice guidelines </h6> <p>Pharmacist prescribers adjusted anticoagulant therapy, as well as an experienced physician, in the independent management of anticoagulation therapy for inpatients. There were no significant differences between groups for mean heparin and warfarin doses, partial thromboplastin time, days to reach therapeutic levels, or mean prescribed and simulated heparin doses (<a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="#CD011227-tbl-0003">Table 2</a>). </p> <div class="table" id="CD011227-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcomes of studies not included in meta‐analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patient group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To compare the effectiveness of pharmacist medication review with or without pharmacist prescribing with standard care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compared with baseline the Chronic Pain Grade improved in prescribing arm 47.7% (21/44; P = 0.003) and review arm 38.6% (17/44; P = 0.001) but not TAU 31.3% (15/48; ns) SF‐12 mental component score showed no effect for prescribing or review arms and deterioration in TAU arm. Hospital Anxiety and Depression scores improved in prescribing arm for depression (P = 0.022) and anxiety (P = 0.007) and between groups (P = 0.022 and P = 0.045 respectively). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anticoagulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacist versus physician independent management of anticoagulant therapy for inpatients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no differences between groups for mean heparin and warfarin doses, partial thromboplastin time, days to reach therapeutic levels, mean prescribed and simulated heparin doses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type 2 diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacist case management versus usual medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the pharmacist case managed group received greater reductions in HbA1c (2.1% vs 0.9%, P = 0.03). Three of five process measures were conducted more frequently in the intervention group than control group. LDL measurement (100% vs 85.7%, P = 0.02), retinal examination (97.3% vs 74.3%, P = 0.004), monofilament foot screening, (92.3% vs 62.9%, P = 0.002). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Family planning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Family planning services provided by nurses versus physicians</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurses' clients were as equally as successful as physicians in continuing contraceptive use and preventing pregnancy. Nurses were less likely than physicians to provide patients on their first visit with IUDs, prescribe oral contraceptives, or sterilisation. Nurses were more likely to give temporary prescriptions than physicians until the next visit (25% vs 16%, P &lt; 0.001) for reasons including possible pregnancy and patients not menstruating. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0012" title="EllisSL , CarterBL , MaloneDC , BillupsSJ , OkanoGJ , ValuckRJ , et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy2000;20(12):1508‐16. ">Ellis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dyslipidaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pharmacists providing pharmaceutical care in addition to usual medical care versus usual medical care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The absolute change in total cholesterol (17.7 vs 7.4 mg/dL, P = 0.028) and LDL (23.4 vs 12.8 mg/dL, P = 0.042) was greater in the intervention than control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prescribing of antiretroviral treatment by nurses versus doctors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort 1 ‐ not receiving antiretrovirals. Time to death did not differ (HR 0.94, 95% CI 0.76 to1.15). </p> <p>Cohort 2 ‐ received antiretrovirals for at least six months. Viral load suppression 12 months after enrolment was equivalent in intervention and control. Risk difference 1.1% (95% CI ‐2.4 to 4.6). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Collaborative care model of clinical pharmacists providing drug therapy management and treatment follow‐up versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical improvements noted in both groups but not significant. Intervention group had higher drug adherence at six months (67% vs 48%; OR 2.17, 95% CI 1.04 to 4.51; P = 0.038) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0015" title="FischerHH , EisertSL , EverhartRM , DurfeeMJ , MooreSL , SoriaS , et al. Nurse‐run, telephone‐based outreach to improve lipids in people with diabetes. American Journal of Managed Care2012;18(2):77‐84. ">Fischer 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lipid control in diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Algorithm‐driven telephone care by nurses as an adjunct to usual care versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The percentage of patients with an LDL &lt; 100 mg/dL increased from 52% to 58.5% in the intervention group and decreased from 55.6% to 46.7% in the control group (P &lt; 0.01). The intervention did not affect glycaemic and BP outcomes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood pressure control in diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A pharmacist‐led intervention (Adherence and Intensification of Medications) in patients with diabetes and poor BP control versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean systolic BP decrease from 6 months before to 6 months after the 14‐month intervention was not different (8.9 mmHg decline in the intervention arm and 9.0 mmHg decline in the control arm). There was no difference in the mean HbA1c and LDL levels between groups after the end of the intervention period (examining 12 months). At the end of the first quarter after activation, there was a significantly greater drop in systolic BP in the intervention group versus control, 9.7 mmHg vs 7.2 mmHg; MD 2.4 mmHg (95% CI 1.5 to 3.4 P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type 2 diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary care nurse management of type two diabetes versus management by GPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>After 14 months between‐group differences for reduction in HbA1c, BP, and lipid profile were not significant. Mean systolic and diastolic BPs were lower in both groups. Most process indicators were significantly better in the nurse care group. More patients were satisfied with their care in the nurse group however the physical component of the SF‐26 was better in the GP group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular risk factors in diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurse case management versus usual care to improve hypertension, hyperglycaemia, and hyperlipidaemia in veterans with diabetes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A greater number of patients in the nurse case management had all three measures under control (21.9% vs 10.1%, P &lt; 0.01). A greater number of intervention group participants achieved individual treatment goals. HbA1c &lt; 8% (73.7% vs 65.8% P = 0.04), BP &lt; 130/80 mmHg (45% versus 25.4%, P &lt; 0.01) but not for LDL &lt; 100 mg/dL (57.6% vs 55.4%, P = 0.61). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐insulin dependent diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacists providing pharmaceutical care versus physicians</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement was seen in glycated haemoglobin in the intervention group at 4 months (9.2% ± 2.1 vs 12.1% ± 3.7, P = 0.003), and fasting plasma glucose (8.5 ± 2.3 vs 11.0 ± 3.9 mmol/L, P = 0.015). There was little or no change within or between groups for BP, lipid profile, renal function, weight, or quality of life measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with signs of incomplete abortion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Midwives diagnosing and treating incomplete abortion with misoprostol compared to physicians </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>452 (95.8%) women in the midwife group and 467 (96.7%) in the physician group had complete abortion. The model risk difference for midwife versus physician group was ‐0.8% (95% CI ‐2.9 to 1.4) falling within the predefined equivalence range (‐4% to 4%). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐inferiority of care provided by a hospital‐based specialised asthma nurse versus a GP or paediatrician </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The corrected daily dose of inhaled corticosteroids as well as the percentage of children prescribed long‐acting beta agonists/inhaled corticosteroids was not significantly different between groups at one and two years. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment of hypertension in the workplace by nurses versus treatment in the community by the family doctor </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the nurse group were more likely to be put on antihypertensive medications (94.7% vs 62.7%, P &lt; 0.001), to reach goal BP in the first six months (48.5 vs 27.5%, P &lt; 0.001) and to take drugs prescribed (67.6 vs 49.1%, P &lt; 0.005). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacist medication history and supplementary prescribing versus pharmacist medication history versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The marginal mean number of missed doses per patient was 3.21 (95% CI 2.89 to 3.52) in the control group, which was reduced in the pharmacist prescribing group 1.07 (95% CI 0.90 to 1.25, P = 0.002) but not in the pharmacist history group 3.30 (95% CI 2.98 to 3.63). The number of medications charted at an incorrect dose or frequency was reduced in the pharmacist history group. The pharmacist prescribing group had less dose errors than the pharmacist history group (P = 0.004). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary prevention of coronary heart disease in primary care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Audit group verus GP recall group versus nurse recall group (disease register and patient recall to nurse‐led clinic) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference occurred in assessment between the nurse and GP recall group. Mean BP, total cholesterol, cotinine levels varied little between groups as did prescribing of hypotensive and lipid‐lowering agents. Prescribing of antiplatelet drugs was higher in the nurse recall group vs GP recall group, MD 8% (95% CI 1% to 15%, P = 0 .031). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary care nurses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Education and implementation of prescribing and clinical guidelines by nurses in rural health centres versus usual nurse care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antibiotic prescribing in children 0 to 5 years for respiratory tract infections fell, (42% at baseline to 27% at follow‐up, control 27% to 30%, P = 0.022). Guidelines had no effect on prescribing antibiotics for diarrhoea but oral rehydration prescribing increased. Diazepam prescribing for adults fell, (intervention 17% to 10%, control 21% to 18%, P = 0.029). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients attending primary care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurse practitioners versus physicians plus conventional nurse in primary care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Similar mortality experience, no differences in physical functioning capacity, social or emotional function. Quality of care similar. In 510 prescriptions, an adequate rating was given to 75% of conventional group and 71% in the nurse practitioner group, probably leading to little difference between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type 2 diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A pharmacist‐led Veterans affairs Multidisciplinary Education and Diabetes Intervention for Cardiac risk reduction (VA‐MEDIC) plus usual care versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>After four months there was a difference (P &lt; 0.05) in the percentage of VA‐MEDIC patients versus controls in attaining target goals for systolic BP &lt; 130 mmHg and HbA1c &lt; 7% but not lipid control or tobacco use. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug therapy in a geriatric setting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug therapy prescribing and patient care management by clinical pharmacists versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The clinical pharmacist group probably had a lower number of deaths (P = 0.05), a higher number of patients being discharged to lower levels of care (P = 0.03) and a lower average number of drugs per patient (P = 0.04). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0044" title="TsuyukiRT , Al HamarnehYN , JonesCA , HemmelgarnBR . The effectiveness of pharmacist interventions on cardiovascular risk. The multicenter randomized controlled RxEACH trial. Journal of the American College of Cardiology2016;67(24):2846‐54. ">Tsuyuki 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients with cardiovascular risk factors associated with hypertension, diabetes, dyslipidaemia and smoking </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community pharmacist care versus usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 3 months the intervention group patients had greater improvements in LDL cholesterol (‐ 0.2 mmol/L, P &lt; 0.001, systolic BP (‐9.37 mmHg, P &lt; 0.001), glycosylated haemoglobin (‐0.92%, P &lt; 0.001) and smoking cessation (20.2%, P &lt; 0.002). </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BP: blood pressure<br/> CI: confidence interval<br/> GP: general practitioner<br/> HbA1c: glycated haemoglobin<br/> HR: hazard ratio<br/> IUD: inter uterine device<br/> LDL: low‐density lipoprotein<br/> MD: mean difference<br/> OR: odds ratio<br/> TAU: treatment as usual </p> </div> </div> </section> <section id="CD011227-sec-0077"> <h6 class="title">5. Proportion of patients demonstrating medication adherence</h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0078"> <h6 class="title">6. Proportion of patients and items appropriately prescribed or deprescribed</h6> <p>Preoperative medication history taking and prescribing by a pharmacist improved the accuracy of medication documentation and significantly reduced missed doses of regular medication for elective surgical patients. The marginal mean number of missed doses per patient was 3.21 (95% confidence interval (CI) 2.89 to 3.52) in the control group, which was significantly reduced in the pharmacist prescribing group 1.07 (95% CI 0.90 to 1.25; P = 0.002) (<a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a>; <a href="#CD011227-tbl-0003">Table 2</a>). </p> </section> <section id="CD011227-sec-0079"> <h6 class="title">7. Patient satisfaction, where measured by a validated tool as part of an effectiveness study </h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0080"> <h6 class="title">8. Non‐medical prescriber versus medical prescriber waiting time to care</h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0081"> <h6 class="title">9. Non‐medical prescribers adversely affecting the health outcomes of patients through medication errors, prescribing errors, adverse events, wrong diagnoses or treatment, increased hospitalisations, or representations for medical care </h6> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> reported no patients had major bleeding but four patients in the pharmacist prescriber group had minor bleeding (one patient had a bleeding facial laceration on admission but a normal prothrombin time). One patient in the physician prescriber group died, after receiving heparin and warfarin for a stroke in evolution, but there was no evidence of bleeding. </p> </section> </section> <section id="CD011227-sec-0082"> <h5 class="title">Secondary Outcomes</h5> <section id="CD011227-sec-0083"> <h6 class="title">Patient‐reported outcomes</h6> <section id="CD011227-sec-0084"> <p><b>1. Health‐related quality of life</b></p> <p>Outcome not reported.</p> </section> </section> <section id="CD011227-sec-0085"> <h6 class="title">Non‐medical prescriber outcomes</h6> <section id="CD011227-sec-0086"> <p><b>1. Job satisfaction, skills utilisation, education needs, and workload effects</b></p> <p>Outcome not reported.</p> </section> </section> <section id="CD011227-sec-0087"> <h6 class="title">Resource‐use outcomes</h6> <section id="CD011227-sec-0088"> <p><b>1. Medical time saved by non‐medical prescribers</b></p> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0089"> <p><b>2. Non‐medical prescriber versus medical prescriber prescription volume and cost, patient out‐of‐pocket expenses, service costs, deprescribing rate, and cost</b></p> <p>There was little or no difference in amount of anticoagulant drugs prescribed by pharmacists compared to a physician (<a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="#CD011227-tbl-0003">Table 2</a>). </p> </section> <section id="CD011227-sec-0090"> <p><b>3. Increased resource use for providing the intervention and for providing subsequent care such as hospitalisations, emergency department visits, and outpatient visits.</b></p> <p>Outcome not reported.</p> </section> </section> </section> </section> <section id="CD011227-sec-0091"> <h4 class="title">Non‐medical prescribing in chronic care (primary/ambulatory care)</h4> <p>We included 40 studies in this comparison. We included ambulatory care clinics for chronic disease management located with secondary care hospitals in this subgroup (<a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a>; <a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a>; <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>). Two studies were undertaken in the community pharmacy setting (<a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a>; <a href="./references#CD011227-bbs2-0044" title="TsuyukiRT , Al HamarnehYN , JonesCA , HemmelgarnBR . The effectiveness of pharmacist interventions on cardiovascular risk. The multicenter randomized controlled RxEACH trial. Journal of the American College of Cardiology2016;67(24):2846‐54. ">Tsuyuki 2016</a>,). </p> <p>Meta‐analyses were undertaken for systolic blood pressure, glycated haemoglobin, and low‐density lipoprotein using the fixed‐effect method for outcomes at six and 12 months (<a href="#CD011227-fig-0003">Figure 3</a>; <a href="#CD011227-fig-0004">Figure 4</a>; <a href="#CD011227-fig-0005">Figure 5</a>). These studies were skewed toward either nurse or pharmacist prescribers, namely, systolic blood pressure at six months (3 nurse studies, 8 pharmacist studies), systolic blood pressure at 12 months (10 nurse studies, 2 pharmacist studies), glycated haemoglobin at six months (1 nurse study, 2 pharmacist studies) glycated haemoglobin at 12 months (6 nurse studies, 0 pharmacist studies), low‐density lipoprotein at six months (4 nurse studies, 2 pharmacist studies), low‐density lipoprotein at 12 months (7 nurse studies, 0 pharmacist studies). </p> <div class="figure" id="CD011227-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.2 Systolic blood pressure mmHg." data-id="CD011227-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.2 Systolic blood pressure mmHg. </p> </div> </div> </div> <div class="figure" id="CD011227-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.1 HbA1c (%)." data-id="CD011227-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.1 HbA1c (%). </p> </div> </div> </div> <div class="figure" id="CD011227-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.3 Low‐density lipoprotein (LDL) mmol/L." data-id="CD011227-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.3 Low‐density lipoprotein (LDL) mmol/L. </p> </div> </div> </div> <p>Moderate or considerable heterogeneity was evident in all subgroups apart from the glycated haemoglobin 12‐month subgroup for which heterogeneity might not be important given an I<sup>2</sup> = 0%. While the degree of heterogeneity provides a caution, studies which contained non‐medical prescribing as an intervention component showed improvement in three surrogate markers of disease; systolic blood pressure, glycated haemoglobin, and low‐density lipoprotein. </p> <p>A single study compared pharmacist case management versus the active control of nurse‐led case management and feedback to primary care physicians for medication adjustment in the secondary prevention after minor stroke (<a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>). Improvements in both systolic blood pressure and low‐density lipoprotein guideline targets were observed in both the pharmacist group (43.4%) and nurse‐led group (30.9%) after six months (absolute difference 12.5%, P = 0.03). Multivariable analyses confirmed the greater attainment of targets in the pharmacist group (adjusted odds ratio (OR) 2.31, 95% CI 1.29 to 4.2; P = 0.005, adjusted for age, comorbidities, sex, smoking status, and waist circumference). Both groups had similar reductions in systolic blood pressure during the trial and the overall result was driven by a higher proportion of patients meeting low‐density lipoprotein targets in the pharmacist‐led group versus the nurse‐led group (51.1% versus 33.8%, P = 0.003). </p> <section id="CD011227-sec-0092"> <h5 class="title">Primary Outcomes</h5> <section id="CD011227-sec-0093"> <h6 class="title">1. Systolic blood pressure</h6> <p>Eleven ambulatory care studies (2076 participants) reporting systolic blood pressure at six months showed a mean difference (MD) favouring the non‐medical prescribing group compared to usual care of ‐6.76 mmHg (95% CI ‐8.24 to ‐5.27; <a href="./references#CD011227-fig-0006" title="">Analysis 1.1</a>), but there was considerable heterogeneity (I<sup>2</sup> = 82%, overall effect P &lt; 0.00001) (<a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a>; <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>; <a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>). At 12 months, 12 ambulatory care studies (4229 participants) showed a MD favouring the non‐medical prescribing group of ‐5.31 mmHg (95% CI ‐6.46 to ‐4.16; <a href="./references#CD011227-fig-0006" title="">Analysis 1.1</a>) with moderate heterogeneity (I<sup>2</sup> = 50%, overall effect P &lt; 0.00001) (<a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a>; <a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0004" title="BeckerDM , YanekLR , JohnsonWR , GarrettD , MoyTF , ReynoldsSS , et al. Impact of a community‐based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation2005;111:1298‐304. ">Becker 2005</a>; <a href="./references#CD011227-bbs2-0017" title="HillMN , HanHR , DennisonCR , KimMT , RoaryMC , BlumenthalRS , et al. Hypertension care and control in undeserved urban African American men: Behavioural and physiological outcomes at 36 months. American Journal of Hypertension2003;16:906‐13. ">Hill 2003</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>; <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>; <a href="./references#CD011227-bbs2-0042" title="TobeS , PylypchukG , WentworthJ , KissA , SzalaiJP , PerkinsN , et al. Effect of nurse‐directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomised controlled trial. Canadian Medical Association Journal2006;174(9):1267‐71. ">Tobe 2006</a>; <a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a>). The test for subgroup differences was not significant (I<sup>2</sup> = 56.3%, P= 0.13) (<a href="#CD011227-fig-0003">Figure 3</a>). </p> <p>The systolic blood pressure effect estimate at six months for the fixed‐effect model was MD ‐6.76 mmHg, 95% CI ‐8.24 to ‐5.27 compared to the random‐effects estimate (MD ‐7.34 mmHg, 95% CI ‐11.09 to ‐3.60). At 12 months the respective comparison was MD ‐5.31 mmHg, 95% CI ‐6.46 to ‐4.16 versus MD ‐5.91 mmHg, 95% CI ‐7.71 to ‐4.10 (<a href="#CD011227-tbl-0002">Table 1</a>). There was a moderate‐certainty of evidence (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Excluding the cluster‐RCT at six months (<a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>), the effect estimate was MD ‐6.13 mmHg, 95% CI ‐7.83 to ‐4.44; 10 studies, 1628 participants (<a href="./references#CD011227-fig-0006" title="">Analysis 1.1</a>.3). Excluding the cluster‐RCTs at 12 months (<a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>), the effect estimate was MD ‐4.84 mmHg, 95% CI ‐6.29 to ‐3.39; 10 studies, 2627 participants (<a href="./references#CD011227-fig-0006" title="">Analysis 1.1</a>.4). </p> <p>The subgroup analysis of four studies (695 participants) where non‐medical prescribers demonstrated a higher level of prescribing autonomy in the control of systolic blood pressure showed: fixed‐effect MD ‐2.98 mmHg, 95% CI ‐5.36 to ‐0.59; P = 0.01, compared with a random‐effects model MD ‐6.78 mmHg, 95% CI ‐15.38 to 1.81; P = 0.12, with considerable heterogeneity I<sup>2</sup> = 90% (<a href="./references#CD011227-fig-0006" title="">Analysis 1.1</a>.5; <a href="#CD011227-fig-0003">Figure 3</a>). </p> </section> <section id="CD011227-sec-0094"> <h6 class="title">2. Glycated haemoglobin</h6> <p>For glycated haemoglobin, three ambulatory care studies at six months demonstrated a MD favouring the non‐medical prescribing group of ‐0.42% (95% CI ‐0.75 to ‐0.09; 271 participants; <a href="./references#CD011227-fig-0007" title="">Analysis 1.2</a>) with moderate heterogeneity (I<sup>2</sup> = 44%, overall effect P &lt; 0.01) (<a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>). At 12 months, six ambulatory care studies managing glycated haemoglobin showed a MD favouring the non‐medical prescribing group of ‐0.62% (95% CI ‐0.85 to ‐0.38; 775 participants) with minimal heterogeneity (I<sup>2</sup> = 0%, overall effect P &lt; 0.00001; <a href="./references#CD011227-fig-0007" title="">Analysis 1.2</a>) (<a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a>; <a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>; <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a>; <a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a>). The test for subgroup differences was not significant (I<sup>2</sup> = 0%, P = 0.35; <a href="#CD011227-fig-0004">Figure 4</a>). For fixed‐effect versus random‐effects estimates refer to <a href="#CD011227-tbl-0002">Table 1</a>. There was a high‐certainty of evidence (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>; <a href="#CD011227-tbl-0002">Table 1</a>). </p> </section> <section id="CD011227-sec-0095"> <h6 class="title">3. Low‐density lipoprotein</h6> <p>Six ambulatory care studies (1213 participants) for low‐density lipoprotein management at six months showed a MD favouring the non‐medical prescribing group of ‐0.25 mmol/L (95% CI ‐0.34 to ‐0.17), but these studies demonstrated considerable heterogeneity (I<sup>2</sup> = 88%, overall effect P &lt; 0.00001; <a href="./references#CD011227-fig-0008" title="">Analysis 1.3</a>) (<a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a>; <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>). At 12 months the MD favouring the non‐medical prescribing group in seven ambulatory care studies was ‐0.21 mmol/L (95% CI ‐0.29 to ‐0.14; 7 studies, 1469 participants; <a href="./references#CD011227-fig-0008" title="">Analysis 1.3</a>). The studies demonstrated considerable heterogeneity (I<sup>2</sup> = 93%; overall effect P &lt; 0.00001) (<a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a>; <a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0004" title="BeckerDM , YanekLR , JohnsonWR , GarrettD , MoyTF , ReynoldsSS , et al. Impact of a community‐based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation2005;111:1298‐304. ">Becker 2005</a>; <a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a>; <a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a>). The test for subgroup differences was not significant (I<sup>2</sup> = 0%, P = 0.53; <a href="#CD011227-fig-0005">Figure 5</a>). There was moderate‐certainty of evidence (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>; <a href="#CD011227-tbl-0002">Table 1</a>). </p> <p>Further exploration of the high heterogeneity in the six‐month low‐density lipoprotein study was undertaken by examining the differences in pharmacist and nurse prescribing. It was found that heterogeneity might not be important in the four pharmacist studies (629 participants) (MD ‐0.09, 95% CI ‐0.20 to 0.02; I<sup>2</sup>= 0%; <a href="./references#CD011227-fig-0009" title="">Analysis 1.4</a>), which did not yield a significantly different overall effect (P = 0.1). Considerable heterogeneity existed in the two nursing studies (584 participants) (MD ‐0.52, 95% CI ‐0.67 to ‐0.38; I<sup>2</sup> = 94%; <a href="./references#CD011227-fig-0009" title="">Analysis 1.4</a>), with a significant overall effect (P &lt; 0.00001). The test for overall effect for both subgroups had considerable heterogeneity and was significant (I<sup>2</sup> = 88%, P &lt; 0.00001). The subgroup differences showed very high heterogeneity and were significant (I<sup>2</sup> = 95.6%, P &lt; 0.00001). For fixed‐effect versus random‐effects estimates refer to <a href="#CD011227-tbl-0002">Table 1</a>. </p> </section> <section id="CD011227-sec-0096"> <h6 class="title">4. Proportion of prescribers, medical and non‐medical, appropriately adhering to practice guidelines </h6> <p>Adherence to practice guidelines was difficult to quantify across studies. Intervention group prescribing was usually aimed at treating a target based on approved therapeutic guidelines. Usual care prescribing may have been based on supplied guidelines, education, or an assumed knowledge of current guidelines. </p> </section> <section id="CD011227-sec-0097"> <h6 class="title">5. Proportion of patients demonstrating medication adherence (Analysis 1.5 and 1.6)</h6> <p>Medication adherence was assessed in 10 studies using a number of approaches including Morisky Medication Adherence Scale, medication possession ratio, patient report, pill count, electronic drug event monitoring, and pharmacy medication refill information (<a href="#CD011227-tbl-0004">Table 3</a>). Medication adherence was reported as high in intervention and usual care groups across studies. There was probably little or no difference between groups in six studies (<a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>; <a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>), and an improved outcome favouring the intervention group in two studies (<a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>). The study by <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> found an improved outcome favouring the intervention group at six months, but no difference between groups at 12 and 18 months. Medication adherence outcomes could not be assessed in the study by <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>. </p> <div class="table" id="CD011227-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Primary outcome ‐ medication adherence</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Medication adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morisky Medication Adherence<br/> Scale </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed adherence at baseline with patients in both groups reporting full adherence.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication possession ratios</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The medication possession ratio (total days' supply of medication divided by total number of expected medication intake days) used in this study found little or no difference between the pharmacist prescribing arm and usual care, even though more medications were prescribed in the pharmacist arm. Adherence was high and ranked above 80%. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication possession ratios</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Determined the medication possession ratio from computerised prescription refill records. Full drug adherence was defined as a medication possession ratio value of 0.83 or more during the six‐month follow‐up. Medication possession ratios at three and six months were probably not different between intervention and control arms even though patients in the intervention group were more likely to change antidepressants. An additional measure, the Health Plan Employer Data Information Set guidelines for successful antidepressant treatment, showed there was little or no difference between groups in compliance with the early phase of treatment, but there was a significant difference in compliance in the intervention group continuation phase. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morisky Medication Adherence</p> <p>Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no differences at study end in the proportions of subjects reporting high medication adherence. There was an improvement in adherence with the groups from baseline to study end. Adherence did not predict goal attainment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐adherence was identified in five of 33 patients with drug therapy problems at baseline, one of 12 patients at six months and one of four patients at nine months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient claim and pill counts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High adherence was judged if patients claimed to be taking their medication as instructed and 80% or more of drugs prescribed were consumed as determined by pill counts. In the nurse intervention group patients were more adherent than the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medication possession ratios</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Little or no difference between groups in the mean medication possession ratio adherence score over the six‐month study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morisky Medication Adherence</p> <p>Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported adherence measured by the Morisky scale modified for blood pressure medications.</p> <p>Adherence to antihypertensive medications at six months increased in the pharmacist intervention telemonitoring group but decreased in the usual care group. There was probably no difference between groups at 12 and 18 months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electronic drug event monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The drug event monitor provided the average number of days on which patients took the correct number of doses prescribed. While adherence was high in both groups, the nurse‐managed patient group had higher adherence than usual care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient self‐reporting and drug refill information from the pharmacy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐adherence was judged as missing more than three doses a week or pharmacy records indicated a failure to refill drugs within two weeks after the scheduled refill date. Little or no difference in adherence between or within the two groups at baseline or the end of the study was found. Over 90% of patients in both groups indicated they took their drugs as directed. The study was underpowered to detect a significant difference in adherence. </p> </td> </tr> </tbody> </table> </div> <p>A meta‐analysis was undertaken for four studies (<a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>; <a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>), with adherence data captured as continuous variables with an outcome probably favouring the intervention group, standardised mean difference (SMD) 0.15 (95% CI 0.00 to 0.30; 700 participants, overall effect P = 0.05) and moderate heterogeneity I² = 38% (<a href="./references#CD011227-fig-0010" title="">Analysis 1.5</a>). Four studies (935 participants) with dichotomous adherence data (<a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>), showed little adherence difference (risk difference (RD) 0.06, 95% CI ‐0.00 to 0.12; P = 0.05) and moderate heterogeneity I<sup>2</sup> = 67% (<a href="./references#CD011227-fig-0011" title="">Analysis 1.6</a>). There was a moderate‐certainty of evidence (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>; <a href="#CD011227-tbl-0002">Table 1</a>). </p> </section> <section id="CD011227-sec-0098"> <h6 class="title">6. Proportion of patients and items appropriately prescribed or deprescribed</h6> <p>In the aged care setting the pharmacist prescribed 2.2 fewer drugs per patient than medical colleagues, comparing before‐and‐after study periods (<a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). <a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a> reported community pharmacist prescribers discontinued 76 antihypertensive drugs in 181 intervention group patients compared to 15 antihypertensive drugs being discontinued in 67 usual care group patients. </p> </section> <section id="CD011227-sec-0099"> <h6 class="title">7. Patient satisfaction, where measured by a validated tool as part of an effectiveness study </h6> <p>Patient satisfaction was reported in 14 studies (7514 participants) (<a href="#CD011227-tbl-0005">Table 4</a>). Validated tools assessing the overall satisfaction with care were included in six studies, namely, diabetes care (<a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a>), hypertension care (<a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>), clinical pharmacist care (<a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>), and general care (<a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>). The majority of satisfaction surveys were not referenced or were locally developed. Some aspects important in the prescribing process were covered in overall satisfaction assessments, e.g. the quantity and quality of contact (<a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a>; <a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>). The locally developed satisfaction survey by <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> focused on the prescribing intervention. Patients were generally positive about the pharmacist prescribing service, 85% (39/46) were totally satisfied, while 9% (4/44) would have preferred to see their general practitioner (GP). Overall, there was a moderate‐certainty of evidence (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>; <a href="#CD011227-tbl-0002">Table 1</a>). Studies looking at medical provider satisfaction with non‐medical prescribers were limited in number and scope (<a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>), but generally positive. </p> <div class="table" id="CD011227-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Secondary outcomes ‐ patient and provider satisfaction</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Satisfaction tool measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19/57 respondents stated that the nurse care management programme was moderately helpful.</p> <p>32/57 found it extremely helpful.</p> <p>9/13 physicians with two or more patients recommended adoption of the nurse management programme. </p> <p>In other health care settings: 9 physicians felt the programme decreased their time with patients, while 4 thought it increased the time spent. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 patient satisfaction statements derived from a local prescribing feasibility study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For the prescribing intervention, patients were generally positive about the pharmacist prescribing service ‐ 85% (39/46) were totally satisfied, while 9% (4/44) would have preferred to see their GP. In semi‐structured interviews with GPs and pharmacists, all pharmacists and most GPs were positive about the intervention. Pharmacists found their role satisfying, interesting, and challenging. 17 of 23 GPs were positive about the pharmacists’ role. The cost‐effectiveness of the pharmacists' role, given limited resources, was one issue raised in the GP focus group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients reported greater treatment satisfaction with the collaborative care model than the control group in 6 of 11 measures including the overall treatment for depression, personal nature of the care, listening to concerns, explanations about why antidepressants were prescribed and how to take them, availability for advice, and overall satisfaction with the organisation. </p> <p>18/37 primary care provider questionnaire respondents were satisfied with workflow, patient welfare. and the pharmacists' abilities. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Evaluation of the Quality of Diabetes Care (PEQD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients' evaluations of their satisfaction with diabetes care from the specialist diabetes nurse were significantly more positive than the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Evaluation of the Quality of Diabetes Care (PEQD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total satisfaction sum score for 14 PEQD measures for practice nurses was 66.4%, compared to 51.7% in the GP group which may be confounded by the amount of time given to each patient. On average GPs spent a total of 28 minutes per patient, whereas practice nurses spent 128 minutes per patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfation in the SF‐36 healthcare domain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with hypertension care was high in both groups, but with little or no difference in any of the 11 satisfaction measures. Satisfaction was not associated with blood pressure goal attainment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22‐item Pharmacist Service Questionnaire.</p> <p>0‐100 scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction with the clinical pharmacist were high, with mean scores 92.4 (±10.9) at 6 months (n = 49) and 92.7 (±11) at 9 months (n = 44). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Satisfaction Questionaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvements in four areas of satisfaction in the intervention group linked to an increased time spent with patients and an emphasis on patient‐centred education and self‐management (i.e. quality and quantity of contact) from base line to study end. Between‐group comparisons at study end demonstrated little or no significant difference in patient satisfaction measures, including overall care and general satisfaction. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6% of patients were dissatisfied with care provided by nurses but details of the survey instrument were not provided: (assumed 12/206 intervention patients at 6 months but not specified). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in overall health care satisfaction between pharmacist‐ and nurse‐led care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients at 6 months reporting they were very or completely satisfied with their hypertension care was probably higher in the intervention group than the usual care group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Six items from the Consumer Assessment of Healthcare Providers and Systems adult survey (version 4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction items concerning clinicians listening carefully, explaining things clearly, and respecting what patients said showed larger improvements amongst patients in the telemonitoring intervention group than usual care at 6 months but not at 12 or 18 months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96% of patients in the nurse practitioner group and 97% of patients in the conventional care group were satisfied with the health services received in the experimental period. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no significant differences in patient satisfaction between groups. More patients in the intervention group felt that the pharmacist spent more time with them than did control patients, although there was little difference. There was no difference in satisfaction with pharmacy services or changes in patient satisfaction in either group from baseline to study end. This study was underpowered to detect a significant difference in patient satisfaction. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>GP: general practitioner</p> </div> </div> </section> <section id="CD011227-sec-0100"> <h6 class="title">8. Non‐medical prescriber versus medical prescriber waiting time to care</h6> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0101"> <h6 class="title">9. Non‐medical prescribers adversely affecting the health outcomes of patients through medication errors, prescribing errors, adverse effects, wrong diagnoses or treatment, increased hospitalisations, or representations for medical care </h6> <p>Adverse events were reported in 18 of the 46 studies (18,400 participants) (<a href="#CD011227-tbl-0006">Table 5</a>). There was probably little or no difference in adverse events between the intervention and usual care groups in nine studies (<a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a>; <a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a>; <a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>; <a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a>; <a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a>; <a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a>; <a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>; <a href="./references#CD011227-bbs2-0042" title="TobeS , PylypchukG , WentworthJ , KissA , SzalaiJP , PerkinsN , et al. Effect of nurse‐directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomised controlled trial. Canadian Medical Association Journal2006;174(9):1267‐71. ">Tobe 2006</a>), with a probable increase in adverse events in the usual care group in two studies (<a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>; <a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). We are uncertain whether the intervention has an effect on adverse events in the remaining studies due to limited data reporting. The relationship between increased medication use in intervention groups and adverse events remains uncertain. Overall, there was a low‐certainty of evidence between the intervention and adverse events (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>; <a href="#CD011227-tbl-0002">Table 1</a>). </p> <div class="table" id="CD011227-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Primary outcome ‐ adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the proportions of patients between control (provider education), nurse facilitator and provider/patient notification for hospitalisations and emergency room visits. There were few deaths with the higher number (7) in the control group which had more patients on haemodialysis, two of whom died. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There appeared little or no difference between intervention and usual care groups for severe low blood glucose events at baseline and during the study period. Mean weight gain differences from insulin treatment in each group or mean weight loss differences with oral agents showed little or no difference. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported no patients had major bleeding, but four patients in the pharmacist prescriber group had minor bleeding (one laceration before hospital). One patient in physician prescriber group died, after receiving heparin and warfarin for a stroke in evolution but there was no evidence of bleeding. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The first year mortality was 3.4% in usual care and 4.1% in the intervention group. However, a longer study is required to show a difference, namely, 2 years plus a 5‐ to 10‐year follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The time to death did not differ between primary care nurses and doctors initiating therapy. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacists identified two adverse drug reactions from 33 drug therapy problems at baseline, two from 12 at six months and none at nine months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events were similar between groups, with no participants withdrawing from the study due to an adverse event, and there was no difference in the rate of hospitalisation or death between the groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported 17 hypoglycaemic reactions in the intervention group and two in the control group. All were considered mild to moderate. The difference was possibly related to increased training in recognition, documentation, and questioning in the intervention group. Three patients were hospitalised, two in the control and one in the intervention group, and these appear unrelated to treatment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In treating incomplete abortion bleeding, the same or less than normal menstrual cycle was probably not different between the intervention midwife and usual care physician groups. There was little difference in pain after treatment as assessed by a visual analogue scale. 30 (6%) of women reported unscheduled visits in the midwife group and 18 (4%) in the physician group. Reasons included vaginal bleeding and abdominal pain. Reported side‐effects after treatment were similar in both groups (nausea, vomiting, abdominal pain, chills, and fever). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no differences between groups (general practitioner, paediatrician, asthma nurse) with respect to the number of severe asthma exacerbations as expressed by the number of prednisolone courses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forty drug‐related adverse events occurred in the intensive intervention group as compared to 10 in the standard group. While the adverse events are known for the drugs in question no further comment was offered. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported few clinical events at six months in a pharmacist‐led intervention for secondary prevention after ischaemic stroke. There were nine cardiovascular events and no deaths in the pharmacist group versus eight cardiovascular events and one death in the nurse‐led group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were 60 adverse events in usual care and 49 in the telemonitoring group; most events were non‐cardiac hospitalisations. There were two allergic reactions to blood pressure medication in the usual care group, six events in the telemonitoring group related to hypotension, dizziness, loss of consciousness which compared to one in the usual care group, four events in usual care related to hypertension versus one in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In patients randomised to specialist nurse‐led clinics for blood pressure control, lipid control or both, there were less deaths in the intervention group (25, (3.2%) versus 36 (5.7%) in the usual care group) odds ratio 0.55 (95% confidence interval 0.32 to 0.92) P = 0.02. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>During the 12‐month experimental period, there were four deaths in the nurse practitioner group and 18 in the conventional care group. There was probably little or no difference in the crude death rate between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no diabetes‐related admissions or deaths for either group during the six‐month study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pharmacist prescribing group in a geriatric setting may have had a slightly lower 12‐month mortality than usual care (3/67 versus 10/72, P = 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0042" title="TobeS , PylypchukG , WentworthJ , KissA , SzalaiJP , PerkinsN , et al. Effect of nurse‐directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomised controlled trial. Canadian Medical Association Journal2006;174(9):1267‐71. ">Tobe 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The incidence of adverse events probably did not differ between the intervention (home care nurse group) and control (primary care physician group) in First Nations people with diabetes and hypertension. Ten patients in the intervention group and seven in the control group required admission to hospital for adverse events. </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD011227-sec-0102"> <h6 class="title">10. Other surrogate outcome markers</h6> <p>Studies of surrogate outcome markers not included in the meta‐analyses reported either probable improvements favouring the intervention over usual care (<a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a>; <a href="./references#CD011227-bbs2-0012" title="EllisSL , CarterBL , MaloneDC , BillupsSJ , OkanoGJ , ValuckRJ , et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy2000;20(12):1508‐16. ">Ellis 2000</a>; <a href="./references#CD011227-bbs2-0015" title="FischerHH , EisertSL , EverhartRM , DurfeeMJ , MooreSL , SoriaS , et al. Nurse‐run, telephone‐based outreach to improve lipids in people with diabetes. American Journal of Managed Care2012;18(2):77‐84. ">Fischer 2012</a>; <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>); little difference in outcome (<a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a>; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>); or uncertainty of outcome, with surrogate markers showing a combination of probable improvements or little difference in outcomes (<a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a>; <a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a>; <a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a>; <a href="#CD011227-tbl-0003">Table 2</a>). </p> </section> </section> <section id="CD011227-sec-0103"> <h5 class="title">Secondary outcomes</h5> <section id="CD011227-sec-0104"> <h6 class="title">Patient‐reported outcomes</h6> <section id="CD011227-sec-0105"> <p><b>1. Health‐related quality of life</b></p> <p>Quality of life measures reflected general non‐medical prescriber care compared to usual care. We combined physical and mental component scores for the Short Form‐12 (SF‐12) and Short Form‐36 (SF‐36) in a meta‐analysis. Eight studies (2385 participants) were included in the physical component meta‐analysis (<a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>; <a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>; <a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>); six studies (2246 participants) contributed to the mental component meta‐analysis (<a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a>; <a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>). The physical subgroups showed a small effect (MD 1.17, 95% CI 0.16 to 2.17, P = 0.02) favouring intervention, with low heterogeneity, I² = 17% (<a href="./references#CD011227-fig-0012" title="">Analysis 1.7</a>). The mental component subgroup did not show an effect difference (P = 0.25) with a MD of 0.58 (95% CI ‐0.40 to 1.55) with moderate heterogeneity, I² = 66% (<a href="./references#CD011227-fig-0012" title="">Analysis 1.7</a>). There was no significant difference between the subgroups (P = 0.41) where heterogeneity might not be a factor, I<sup>2</sup> = 0%. </p> <p>Across studies, various quality of life measures generally demonstrated little difference between intervention and control groups (<a href="#CD011227-tbl-0007">Table 6</a>). There was a moderate‐certainty of evidence (<a href="./full#CD011227-tbl-0001">summary of findings Table for the main comparison</a>; <a href="#CD011227-tbl-0002">Table 1</a>). </p> <div class="table" id="CD011227-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Secondary outcome ‐ quality of life</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four generic quality of life measures from the</p> <p>Behavioural Risk Factor Surveillance System</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention and control groups reported improved perception of health status after 12 months, but intervention patients were twice as likely to report this. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36, the Duke Activity Status Index for QoL, and the BDI for depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences for any of the variables, but an improved mood for both groups was found. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐12, HUI, CPG, and HADS‐D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No one measure was seen as the primary outcome. In the prescribing arm there was a within‐arm improvement for CPG intensity and disability effect size subscales and between arms on the intensity subscale but not the disability subscale. There was a within‐arm improvement in overall CPG in the prescribing and review arms but not the TAU arm. The SF‐12 and HADS‐D showed deterioration in the TAU arm. Compared with baseline, patients had an improved CPG in the prescribing and review arms but not the TAU arm. The SF‐12 physical score difference showed no effect in prescribing or review arms but improvement in the TAU arm. SF‐12 mental score showed no effect in prescribing or review arms and deterioration in the TAU arm. HADS‐D scores within the prescribing arm showed improvement for depression and anxiety which were also significant between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 for Veterans</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no change in quality of life scores over 6 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Brief Inventory for depressive symptoms and Work and Social Disability Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Liitle or no difference at 6 months between intervention and control groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 and the revised version of the Type 2 Diabetes Symptom Checklist to measure the presence and perceived burden of diabetes‐related symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences over 12 months between groups in either survey.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 and the revised version of the Type 2 Diabetes Symptom Checklist to measure the presence and perceived burden of diabetes‐related symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the control group there were little or no differences between baseline and follow‐up SF‐36 measures, however in the practice nurse intervention group there were differences in physical functioning, role physical, vitality, and the physical component score. Little or no differences were seen in the QoL results over time between the two groups except for the physical component score which was lower in the intervention group. After 14 months responses to the revised Type 2 Diabetes Symptom Checklist revealed little or no differences between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference except in the general health domain with scores higher in the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health Status Questionnaire version 2 derived from the SF‐36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference between or within groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36, Seattle Angina Questionnaire and LVD‐36 questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Differences favouring the intervention group were found in the SF‐36 for physical functioning, general health, vitality, social functioning, and mental health. Seattle Angina Questionnaire scores in patients with angina were significantly better for intervention patients compared to controls for exertional capacity and borderline differences were found for angina frequency and QoL. There was little or no difference in any of the SF‐36 health status domains or LVD‐36 scores for patients with a confirmed diagnosis of left ventricular diastolic dysfunction. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐12</p> <p>Diabetes Quality of Life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference between groups in either measure at study end.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐related health using a Likert scale</p> <p>The EQ‐5D as an index of health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference between the pharmacist‐ and nurse‐led groups in participants overall self‐related health. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences between groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dartmouth COOP charts EuroQol scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no or clinically important differences between groups for any dimension.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the nurse practitioner and usual care groups had similar values at baseline and study end for physical, emotional, and social function. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change from baseline in depression symptoms by the PHQ‐9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Even though no pharmacologic treatments for depression symptoms were offered as part of the intervention, the mean change in PHQ‐9 scores was probably not different for intervention and standard care participants. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no significant differences either between or within the two groups from baseline to study end, although patients in the control group reported more bodily pain . </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BDI: Beck Depression Index<br/> CPG: Chronic Pain Grade<br/> EQ‐5D: EuroQol five dimensions questionnaire<br/> HADS‐D: Hospital Anxiety and Depression Scale<br/> HUI: Health Utilities Index<br/> LVD‐36: Left Ventricular Dysfunction<br/> PHQ‐9: Patient Health Questionnaire‐9<br/> QoL: quality of life<br/> SF‐12: Short‐Form‐12<br/> SF‐36: Short‐Form‐36<br/> TAU: treatment as usual </p> </div> </div> </section> </section> <section id="CD011227-sec-0106"> <h6 class="title">Non‐medical prescriber outcomes</h6> <section id="CD011227-sec-0107"> <p><b>1. Job satisfaction, skills utilisation, education needs, and workload effects</b></p> <p>Outcome not reported.</p> </section> </section> <section id="CD011227-sec-0108"> <h6 class="title">Resource use outcomes</h6> <section id="CD011227-sec-0109"> <p><b>1. Medical time saved by non‐medical prescribers</b></p> <p>Outcome not reported.</p> </section> <section id="CD011227-sec-0110"> <p><b>2. Non‐medical prescriber versus medical prescriber prescription volume and cost, patient out‐of‐pocket expenses, service costs, deprescribing rate, and cost</b></p> <p>Medication use, including medication amount, medication type, medication dosing, medication frequency, and medication cost was higher in 14 non‐medical prescribing groups (7092 participants) compared to usual care (<a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a>; <a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a>; <a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a>; <a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a>; <a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a>; <a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a>; <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a>; <a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a>; <a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a>; <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>; <a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a>; <a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a>; <a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a>; <a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a>). Little difference in medication use was reported in two studies (<a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a>) (137 participants), and a variable outcome was reported in six studies (7924 participants) (<a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a>; <a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a>; <a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a>; <a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a>; <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>; <a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a>). (<a href="#CD011227-tbl-0008">Table 7</a>). </p> <div class="table" id="CD011227-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Secondary outcome ‐ resource use</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Medication and related therapy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>β‐blocker use was higher in the nurse facilitator group with two‐thirds of patients either initiated or up‐titrated on β‐blockers versus fewer than one‐third of patients in the other two study arms (control provider education and provider/patient notification). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in amount of anticoagulant drugs prescribed by pharmacists compared to a physician. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More patients in the pharmacist prescribing arm were prescribed diuretics and sulphonylureas compared to usual care. Overall there was an increase in the number of medications prescribed by pharmacists for hypertension, diabetes, and cholesterol from baseline to six months, but little or no change in the usual care arm. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In nurse‐led clinic for hypertension management in diabetics at six months there were increased changes in the proportions of patients receiving new prescriptions for calcium channel blockers and thiazide diuretics as intensification therapy. The median number of drugs per patient increased in the intervention group compared to conventional primary care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In a family medicine clinic in Bogota, nurses were less likely than physicians to provide intrauterine devices, prescribe oral contraceptives, and sterilisation on the patient's first visit. Nurses were more likely than physicians to provide temporary prescriptions and defer intrauterine devices and contraceptive measures if the patient on their first visit was not menstruating or believed to be pregnant. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational cohort results taken six months following the quarter start date showed intervention patients had more blood pressure medication changes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacists identified at least one hypertension drug therapy problem in 33/73 (45.2%) patients at baseline requiring additional therapy in 14/33 (42.4%) and dosage increases in 11/33 (33.3%). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The nurse specialist in diabetes prescribed significantly more antihypertensive agents and the internist (doctor control) prescribed more cholesterol‐lowering agents. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean number of antihypertensive medications per patient and use of generic antihypertensive agents was higher in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the nurse‐managed group were more likely to be put on antihypertensive medications, prescribed more than two pills per day, and to be on more than one antihypertensive medication. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were more intervention intensive group patients on three or more antihypertensive drugs (at the study beginning more patients in the standard care group were on three or more antihypertensive agents). At the end of the study more patients with dyslipidaemia in the intensive group were receiving statin therapy. More patients in the intervention group were on aspirin antiplatelet therapy at the end of the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The median number of antihypertensive medications taken at six months was probably not different in the pharmacist‐ and nurse‐led groups. There was a difference favouring pharmacists in maximal dosing of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers at six months, but not the percentage of patients using these drugs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In patients completing the six‐month visit, there were more intervention patients that had an antihypertensive medication added to their regimen and a dose increased for existing medication, than usual care patients. There was an increase in the usage of specific antihypertensive drugs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were increases in the mean number of antihypertensive medication classes at 6, 12, and 18 months in the intervention group compared to baseline and compared to usual care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was minimal change in prescribing antihypertensive drugs in the three groups. All groups increased prescribing of lipid‐lowering drugs but there was little or no difference between groups. There was an increase of 10% more patients’ prescribed antiplatelet treatment in the nurse recall group versus the audit group and 8% more in the nurse recall group versus the general practitioner recall group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In examining the effects of training and guidelines on prescribing by nurses, the mean change in antibiotic prescribing for all patients showed little or no difference. The mean change for antibiotic prescribing for respiratory infections in children (0 to 5 years) fell. No change was detected in prescribing antibiotics for diarrhoea. There was a mean fall in diazepam prescribing in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the nurse management patient group at six months there was an increased number and variety of antihypertensive medications and an increased number of medication changes than in the usual care group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention arm group (VA‐MEDIC) had greater dose titrations of antihypertensive medications, insulin, statins, and niacin compared to the usual care arm. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention arm participants (VA‐MEDIC‐D) had more dose increases or initiation of any antihypertensive agents and more dose increases or initiation of antihyperglycaemic agents. There was little or no difference in the initiation or dose titration of any antihyperlipidaemic agent or antidepressants. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The average number of drugs prescribed per patient was lower in the pharmacist group compared to the physician group. The number of drugs was reduced by an average of 2.2 drugs per patient from the pre‐study to the study year. The practice of clinical pharmacists prescribing drug therapy under physician supervision has the potential to save the healthcare system USD 70,000 per 100 skilled nursing facility beds. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the pharmacist prescribing arm proportionally more new antihypertensive agents were initiated, more dose changes occurred, more antihypertensives were discontinued, and more patients were prescribed low‐dose aspirin and a statin than in the usual care group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the type of antihypertensives prescribed to intervention and control patients during the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compared with baseline there were more patients in both groups taking antihypertensive medications but this difference was probably only important in the nurse‐led intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Healthcare visits, health resources, and associated costs</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in hospitalisations and emergency room visits between the three groups of control (provider education), nurse facilitator, and provider/patient notification. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions were rare and did not differ between the intervention and usual care groups. ED visits did not differ between groups or from baseline. No hospital or ED visits were related to diabetes. The average number of outpatient visits during the study was similar. The nurse managed a case load of 71 patients, but it was estimated that a 300 patient case load could be managed. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no change in health utilisation (physician visits, ED visits, days of hospitalisation) for the year before and after the intervention and between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In reporting process measures for the clinical pharmacist’s case management of patients there was a difference between pharmacist intervention and control in the frequency of low‐density lipoprotein measurements, retinal examinations, and monofilament foot examinations but not glycated haemoglobin measurement or urine albumin screen. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over six months there were a higher number of primary care visits in the usual care arm; an average 1.65 visits per patient versus 1.56 in the intervention arm. It was suggested the difference in the higher number of primary care visits may offset the intervention cost. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The nursing time spent in the year after myocardial infarction was nine hours per patient; a per patient cost of USD 500 which included the nurse salary, office costs, and other associated costs. This compared with cardiac rehabilitation programmes in the San Francisco Bay area costing USD 1800 to USD 2700 to participate for three months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0012" title="EllisSL , CarterBL , MaloneDC , BillupsSJ , OkanoGJ , ValuckRJ , et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy2000;20(12):1508‐16. ">Ellis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In investigating the impact of clinical pharmacist interventions in patients with dyslipidaemia there was little or no difference in physician or nurse visits between control and the intervention patients at 12 months. At 12 months the intervention group had more pharmacist visits than the control group. There were little or no difference in costs for hospitalisations, clinic visits, laboratory costs, drug costs, and costs of lipid therapy between groups. The intervention group had a USD 370 greater difference per patient in total costs which was probably not important and approximately 5% of total costs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the cohort of patients not yet receiving antiretroviral therapy there was little or no difference in clinic visits with a nurse but clinic visits with a doctor were probably higher in the intervention group. </p> <p>In the cohort of patients who had already received at least six months of antiretroviral therapy clinic visits with a nurse probably higher in the intervention group. Economic data from the study is the subject of further analysis by <a href="./references#CD011227-bbs2-0159" title="BartonGR , FairallL , BachmannMO , UebelK , TimmermanV , LombardC , et al. Cost‐effectiveness of nurse‐led versus doctor‐led antiretroviral treatment in South Africa: pragmatic cluster randomised trial. Tropical Medicine and International Health2013;18(6):769‐77. ">Barton 2013</a> (see <a href="./references#CD011227-bbs1-0003" title="">Studies awaiting classification</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Although the collaborative care model experienced a decrease in the total number of primary care visits, the between‐group difference was probably not important. ED visits increased more in the usual care group but this was probably not important and neither was the difference in utilisation of psychiatric services. The institutional cost of drugs, the cost of antidepressants and the cost of psychotropic drugs overall was higher in the intervention group, but this was not important. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0015" title="FischerHH , EisertSL , EverhartRM , DurfeeMJ , MooreSL , SoriaS , et al. Nurse‐run, telephone‐based outreach to improve lipids in people with diabetes. American Journal of Managed Care2012;18(2):77‐84. ">Fischer 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions (while trending to fewer admissions) in the nurse intervention group showed little or no difference to the control group. Nurse case management was not associated with a significant difference in the number of outpatient or ED visits. There was a decrease in total costs in the nurse telephone intervention group comparing the period before and after randomisation. In contrast, there was an increase for the same comparison in the control group. Similar results were seen with hospitalisation and ED costs which were lower in the intervention group. There was probably not an intervention effect on outpatient costs. The difference in average per patient cost between the intervention group (USD 6600) and control group (USD 9033) of USD 2433 was important. The control group had higher baseline hospitalisation rates and total costs cautioning interpretation of the result. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in health services utilisation (hospitalisations, primary care visits, ED visits) between intervention and control patients during the 14‐month study of blood pressure control through a clinical pharmacist outreach programme in diabetic patients. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pharmacist collaborative group (PharmD‐PCP MTM) had fewer primary care physician visits during the intervention period than did the usual care group. The mean total combined visits of primary care physician and pharmacist was not greater in the PharmD‐PCP MTM group than in usual care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a lower number of visits in the NSD group compared with standard care but not in the duration of visits. Significantly more patients were referred back to their GP by the NSD when meeting treatment goals. Personnel and laboratory costs were lower in the intervention group than the control group. The average per month increase in medication costs between the groups was probably not important apart from the cholesterol‐lowering medications. The average time saving per internist was 61.4 minutes (meaning the internist could supervise 11 patients with the NSD in the time he/she could treat one patient). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean number of visits and duration of visits was higher in the practice nurse intervention group than the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total number of clinic visits (physician plus pharmacist) was higher in the intervention arm compared to the control arm. The number of physician visits was lower in the intervention arm. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in the hospitalisation rate between intervention and control groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In testing the non‐inferiority of asthma care in children with stable asthma provided by a hospital‐based specialised asthma nurse versus a GP or paediatrician, there was little or no differences between the groups for medication, school absence or parental work absence after two years. There was little or no difference in unplanned visits and no hospital admissions during the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medium number of outpatient visits were higher for the team based intervention patients. Average personnel costs for one year's treatment were significantly higher in the intervention group (USD 134.68 vs USD 93.70, P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the mean number of outpatient clinic visits, total number of ED visits, and hospitalisations between the two groups. The intervention group probably had a higher number of email and telephone encounters. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over 12 months in the telemonitoring intervention group all 228 patients used a mean of 11.4 ± 3.9 pharmacist visits lasting a mean of 34.2 minutes and 217 used telemonitoring services with a mean of 9.8 ± 2.5 months of use. It was estimated direct programme costs would total USD 1350 per patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A reported five per cent drop in gross practice revenue was explained by the absence of billing for services provided by the nurse practitioner. Billing for unsupervised practice was not permitted in Ontario at the time of the study. During the trial year the services rendered by the nurse practitioner were worth approximately USD 16,000 of which almost 50% was for unsupervised practice. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no differences in primary carer visits, use of ED services for all cause visits, diabetes‐related ED visits or hospital admission rates. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the average length of stay or hospitalisations although the latter trended lower in the pharmacist group. Differences favouring the pharmacist group were found in the rate of discharge to home or to a lower level of care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences between intervention and control groups in appointments with the primary care provider during the 6 months of the study. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ED: emergency department<br/> GP: general practitioner<br/> NSD: nurse specialised in diabetes </p> </div> </div> <p>Costs relating to prescription volume, patient out‐of‐pocket expenses, and deprescribing rate were not reported. </p> </section> <section id="CD011227-sec-0111"> <p><b>3. Increased resource use for providing the intervention and for providing subsequent care such as hospitalisations, emergency department visits, and outpatient visits</b></p> <p>Twenty‐five studies (22,590 participants) reported resource use, including hospital admissions, emergency department visits, outpatient visits, primary care visits, physician visits, pharmacists’ visits, examinations, and staff and laboratory costs (<a href="#CD011227-tbl-0008">Table 7</a>). Due to the heterogeneity of resource use across studies and the measures used to record resource use, meta‐analysis was confined to a limited number of studies of emergency department visits (RD 0.01, 95% CI ‐0.02 to 0.03) and hospitalisation (RD ‐0.01, 95% CI ‐0.03 to 0.01) comparing the non‐medical prescribing group to usual care. There was no statistical difference between study groups for these parameters (P = 0.52 and P = 0.51, respectively) in the meta‐analysis (<a href="./references#CD011227-fig-0013" title="">Analysis 1.8</a>). There appeared to be little difference in hospitalisations, emergency department visits, and outpatient visits between intervention versus control groups across the studies. </p> </section> </section> </section> </section> <section id="CD011227-sec-0112"> <h4 class="title">Non‐medical prescribing in other settings</h4> <p>Two studies were undertaken in other settings. <a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> described a study of blood pressure control by nurses in the workplace compared to usual medical care. Patients in the nurse group were more likely to be put on antihypertensive medications (94.7% versus 62.7%, P &lt; 0.001), to reach blood pressure goals in the first six months (48.5 versus 27.5%, P &lt; 0.001) and to take drugs prescribed (67.6 versus 49.1%, P &lt; 0.005). <a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> reported on pharmacist prescribing in a geriatric setting. The clinical pharmacist group probably had a lower number of deaths (P = 0.05), a higher number of patients being discharged to lower levels of care (P = 0.03) and a lower average number of drugs per patient (P = 0.04) (<a href="#CD011227-tbl-0003">Table 2</a>). </p> <p>Four studies were undertaken in low‐ and middle‐income country settings. <a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a> evaluated nurse management versus usual doctor care of family planning and prescribing oral contraceptives. While differences in patient management occurred, the outcomes of continuing oral contraceptive use and preventing pregnancy were probably not different. As outlined, <a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> evaluated task shifting of antiretroviral therapy from doctors to primary care nurses. The intervention improved survival slightly in patients not yet taking antiretrovirals with CD4 counts of 201 to 350 cells per µL but resulted in little difference in patients with higher cell counts. There was little or no difference in viral load suppression between patient groups for patients already taking antiretrovirals at enrolment. <a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a> compared treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda and found the diagnosis and treatment of incomplete abortion by midwives equally safe and effective as when provided by physicians. In the study by <a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>, educational intervention with guidelines for nurses probably improved antibiotic prescribing for acute respiratory tract infections and the prescribing of diazepam. There was probably no difference in the prescribing of antibiotics for diarrhoea, and it is uncertain whether diabetes care improved because the certainty of evidence is low. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011227-sec-0113" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011227-sec-0113"></div> <section id="CD011227-sec-0114"> <h3 class="title" id="CD011227-sec-0114">Summary of main results</h3> <p>The overall findings suggest that non‐medical prescribing practised with varying but high degrees of autonomy and with collaborative support, can deliver comparable outcomes to usual medical care prescribing. However, these results must be interpreted with a degree of caution, recognising the variation in non‐medical prescribing practice reported within studies and the complex interplay of factors affecting outcomes. There are a limited number of well‐designed randomised controlled trials (RCTs) evaluating the specific prescribing outcomes of non‐medical prescribers. </p> <p>Meta‐analyses examining surrogate markers of disease with the fixed‐effect method demonstrated interventions with a non‐medical prescribing component decreased systolic blood pressure at six months by ‐6.76 mmHg, and at 12 months by ‐5.31 mmHg. The fixed‐effect estimates gave a more conservative estimate of effect than the random‐effects estimate for systolic blood pressure ( ‐7.34 mmHg and ‐5.91 mmHg, respectively). There was little difference between fixed‐ and random‐effects outcomes for glycated haemoglobin at six months (‐0.42% versus ‐0.45%, respectively) and at 12 months (‐0.62% versus ‐0.62%, respectively). Reductions in low‐density lipoprotein demonstrated variable results using fixed‐ and random‐effects at six months (‐0.25 mmol/L versus ‐0.13 mmol/L, respectively), and 12 months (‐0.21 mmol/L versus ‐0.30 mmol/L, respectively). However, all studies apart from those assessing glycated haemoglobin at 12 months demonstrated moderate to considerable heterogeneity. Removal of the two cluster‐RCTs for systolic blood pressure reduced the fixed‐effect difference by 0.63 mmHg at six months and 0.47 mmHg at 12 months. </p> <p>Clinical findings of interventions with non‐medical prescribing components outside the meta‐analyses showed equivalence or benefit compared to usual care (<a href="#CD011227-tbl-0003">Table 2</a>). Medication adherence was measured in less than a quarter (22%) of studies. Where adherence was measured, there was either no difference between study groups or a small improvement in intervention groups. More regular contact by the non‐medical prescriber with intervention patients compared to usual care may be a confounding factor. For example, in the telemonitoring of blood pressure study by <a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a>, which demonstrated improved medication adherence at six months, there was regular telephone support from the intervention pharmacist every two weeks until blood pressure control was sustained for six weeks. Contact then reduced to monthly contact for six months which may account for little or no difference in medication adherence at 12 and 18 months. A meta‐analysis of four studies with continuous adherence data favoured the non‐medical prescriber group with minimal heterogeneity. </p> <p>In studies reporting adverse events, there was either little difference between intervention and usual care groups or insufficient information to determine if differences occurred. In two studies, more deaths were reported in the usual care group versus the intervention group (<a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a>; <a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). </p> <p>The meta‐analysis of the quality of life measures (SF‐12 and SF‐36 scores at 12 months) probably showed a small improvement favouring the intervention. A variety of other quality of life measures (used in the remaining studies and not included in the meta‐analysis) generally demonstrated little difference between the intervention and usual care groups. In assessing quality of life effects, consideration must be given to the effect of the multifaceted nature of many interventions beyond the non‐medical prescribing component. </p> <p>Patient satisfaction data were reported in 14/46 (30%) of studies and focused on the care patients received from the non‐medical health professional as a whole, with little specific comparative evidence of satisfaction with the prescribing element of care. <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> obtained a high patient satisfaction rating of 85% (39/46) with the pharmacist service involving prescribing and education in the management of chronic pain. Two studies included results of small samples of medical provider satisfaction with non‐medical providers, which were generally positive, but they raised respective concerns about time commitments to intervention patients and the cost‐effectiveness of non‐medical prescribers (<a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a>; <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>). </p> <p>A wide variety of measures of resource use were reported in 37/46 (80%) of studies. In the majority of studies reporting medication use, non‐medical prescribers initiated and prescribed more drugs, titrated drugs to a higher dose, and used a greater variety of drugs than usual care medical prescribers in treating chronic disease. In the aged care setting, the pharmacist prescribed fewer drugs than medical colleagues (<a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a>). There was little difference in hospitalisations, emergency department visits, and outpatient visits between intervention versus usual care groups across the studies. </p> <p>Non‐medical prescribers had varying levels of prescriber training, determined by country or setting, and no studies were found comparing different levels of non‐medical prescriber training and outcomes. </p> </section> <section id="CD011227-sec-0115"> <h3 class="title" id="CD011227-sec-0115">Overall completeness and applicability of evidence</h3> <p>The majority of studies were from high‐income countries with the greater proportion, 25 of 46 studies emanating from the USA. While the results of this review are more applicable in Western countries, the four studies involving non‐medical prescribing nurses in low‐ and middle‐income countries demonstrated safe and effective outcomes compared to usual care, and provide an opportunity for further study in the application of non‐medical prescribing. It is unclear why more studies meeting inclusion criteria did not originate from the UK where legislative change and formal training requirements have allowed independent prescribing by nurses and pharmacists since 2006. Chronic disease management was the focus of most studies with only two studies undertaken in the acute inpatient secondary care setting (<a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a>; <a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a>). </p> <p>No studies reported comparisons between non‐medical prescribers in both arms of the study. </p> <p>In only 19 studies could a more defined non‐medical prescribing role with less confounding elements provide a clearer effect on outcomes. Pharmacists were judged to have more autonomy in their prescribing roles than nurses, who relied more heavily on algorithms to adjust medications. The degree of prescribing autonomy within study designs was guided by local legislative controls and healthcare organisation policies and practices. </p> <p>Formal training as a requirement to prescribe was limited. Independent pharmacist prescribers in the <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> UK study were required to complete a course of approved study and have registration with the General Pharmaceutical Council as independent prescribers. In Alberta Canada, pharmacists in the Tsuyuki studies were required to undergo an assessment process when applying for the authorisation to prescribe (<a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a>; <a href="./references#CD011227-bbs2-0044" title="TsuyukiRT , Al HamarnehYN , JonesCA , HemmelgarnBR . The effectiveness of pharmacist interventions on cardiovascular risk. The multicenter randomized controlled RxEACH trial. Journal of the American College of Cardiology2016;67(24):2846‐54. ">Tsuyuki 2016</a>). In other studies, prescribing permissions were granted through collaborative practice agreements for pharmacists in the USA, and varying degrees of specific on‐the‐job training for the disease or condition of focus. Prescribers frequently had advanced practice qualifications, for example, in diabetes management, and a number of years of experience in ambulatory chronic disease care. Prescribing of oral contraceptives was within the remit of family planning nurses in Bogota, Colombia (<a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a>). Local training was provided to nurses in South Africa covering antiretroviral drug prescribing, drug effects and side‐effects, and the use of algorithmic clinical practice guidelines (<a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a>). Midwives in Uganda underwent a five‐day training programme covering incomplete abortion and treatment with misoprostol (<a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a>). Nurses in health centres in Thailand prescribed antibiotics for children and diazepam for adults without additional education and guideline support, which was the focus of the study (<a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a>). </p> <p>The heterogeneity of educational requirements for non‐medical prescribers across studies did not allow a pooled assessment of outcomes, but within individual studies the education level did not appear to influence the outcome. </p> <p>Local trial protocols, which included additional collaborative medical support for the non‐medical prescriber, were aimed at ensuring safe practice. </p> <p>Most excluded studies were before‐and‐after studies and there remains a need for further large, well‐controlled trials, where the prescribing component can be clearly associated with an outcome, and the degree of prescribing autonomy is clearly defined. </p> <p><a href="./references#CD011227-bbs2-0162" title="MikulsTR , CheethamTC , RashidN , LevyGD , KerimianA , LowKJ , et al. A pragmatic cluster‐randomized controlled trial of an automated, pharmacy‐based intervention to optimize allopurinol therapy in gout. Arthritis and Rheumatology2015;67:Suppl 10. ">Mikuls 2015</a> is an ongoing study (see <a href="./references#CD011227-sec-0142" title="">Characteristics of ongoing studies</a>). We are waiting for further information from one study that is reported as an abstract (<a href="./references#CD011227-bbs2-0161" title="TsuyukiRT , RosenthalMM , PearsonGJ . Improving dyslipidemia management in the community: A randomized trial of pharmacist prescribing, The RxACT study. Canadian Journal of Cardiology2014;30(10):S118‐9. ">Tsuyuki 2014</a>). We have placed this study in <a href="./references#CD011227-sec-0141" title="">Characteristics of studies awaiting classification</a> and we will incorporate this study in a future review update. Two further studies, assessing economic impacts, are awaiting assessment (<a href="./references#CD011227-bbs2-0159" title="BartonGR , FairallL , BachmannMO , UebelK , TimmermanV , LombardC , et al. Cost‐effectiveness of nurse‐led versus doctor‐led antiretroviral treatment in South Africa: pragmatic cluster randomised trial. Tropical Medicine and International Health2013;18(6):769‐77. ">Barton 2013</a>; <a href="./references#CD011227-bbs2-0160" title="NeilsonAR , BruhnH , BondCM , ElliottAM , SmithBH , HannafordPC , et al. Pharmacist‐led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial. BML Open2015;5:e006874. [DOI: 10.1136/bmjopen‐2014‐006874] ">Neilson 2015</a>). We made the pragmatic decision that these two studies will be incorporated in the update of this review, so as to avoid delaying the publication of the current version of this review. </p> </section> <section id="CD011227-sec-0116"> <h3 class="title" id="CD011227-sec-0116">Quality of the evidence</h3> <p>We evaluated the certainty of the body of evidence for seven outcomes according to the GRADE system. </p> <p>We graded the certainty of evidence for systolic blood pressure at 12 months as moderate due to considerations of serious inconsistency (finding considerable heterogeneity), the multifaceted nature of interventions, and variable prescribing autonomy. We found high levels of certainty of evidence for the outcome of glycated haemoglobin at 12 months. There were low levels of certainty of evidence for low‐density lipoprotein due to serious inconsistency (finding considerable heterogeneity), multifaceted interventions, and variable prescribing autonomy. We graded medication adherence at moderate‐certainty of evidence due to serious risk of bias (high risk of performance bias) and variable adherence reporting measures. We graded the certainty of evidence around adverse event reporting as low due to indirectness, as the range of adverse events may not be related to the intervention, and selective outcome reporting with adverse events not being reported in many studies. We graded the certainty of evidence for patient satisfaction as moderate due to indirectness in measuring the prescribing component of care, the variability of measures used, and the consideration that some measures were not validated. We graded the health‐related quality of life measures as moderate, considering that within the quality of life outcomes it is difficult to distinguish the contribution non‐medical prescribing made to the outcome versus the other components of care. </p> <p>The certainty of the body of evidence provides support that there is probably no difference in outcomes between non‐medical and medical prescribers. Specific outcomes may be improved by non‐medical prescribers working within collaborative care arrangements in a range of settings. </p> </section> <section id="CD011227-sec-0117"> <h3 class="title" id="CD011227-sec-0117">Potential biases in the review process</h3> <p>Differing terminologies for non‐medical prescribing across countries may have limited the number of studies found. In addition, we made judgements on the degree of prescribing autonomy for non‐medical prescribers in included studies. </p> </section> <section id="CD011227-sec-0118"> <h3 class="title" id="CD011227-sec-0118">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are generally consistent with the findings of other reviews. Meta‐analyses of studies involving pharmacist and nurse‐led care may include studies involving medication management, medication reconciliation, medication education, treatment monitoring, treatment support, and lifestyle advice. Medication management is a broad term that may or may not include a prescribing component. Subgroup analysis of studies involving either independent prescribing, prescribing or dosage adjustment by protocol or algorithm have demonstrated benefit over usual care. Findings of improvements in clinical markers and heterogeneity accord with our findings. In a meta‐analysis, <a href="./references#CD011227-bbs2-0202" title="SantschiV , ChioleroA , ColosimoAL , PlattRW , TaffeP , BurnierM , et al. Improving blood pressure control through pharmacist interventions: A meta‐analysis of randomized controlled trials. Journal of the American Heart Association2014;3(2):e000718. [DOI: 10.1161/JAHA.113.000718] ">Santschi 2014</a> reported pharmacist interventions improved blood pressure compared to usual care, but due to the large heterogeneity between studies the effect size varied widely, and it was difficult to determine the most effective intervention. A range of pharmacist interventions were found to reduce systolic blood pressure, but possibly not diastolic blood pressure (<a href="./references#CD011227-bbs2-0193" title="MachadoM , BajcarJ , GuzzoG , EinarsonTR . Sensitivity of patient outcomes to pharmacist interventions. Part 11: Systematic review and meta‐analysis in hypertension management. Annals of Pharmacotherapy2007;41(11):1770‐81. ">Machado 2007</a>). A limitation for both studies was the quality of the studies included in the analyses. In a systematic review of the effects of nurse prescribing, <a href="./references#CD011227-bbs2-0177" title="GielenSC , DekkerJ , FrankeAL , MistiaenP , KroezenM . The effects of nurse prescribing: A systematic review. International Journal of Nusring Studies2014;51:1048‐61. ">Gielen 2014</a> reviewed 35 studies including 10 RCTs and one controlled clinical trial. All but five studies had a high risk of bias, but tentative conclusions were that nurses prescribed in a similar way to doctors with few differences in health outcomes, quality of care, and patient satisfaction. <a href="./references#CD011227-bbs2-0166" title="ClarkCE , SmithLFP , TaylorRS , CampbellJL . Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta‐analysis. BMJ2010;341:c3995. [DOI: 10.1136/bmj.c3995] ">Clark 2010</a> found nurse‐led interventions required an algorithm to improve blood pressure control compared to usual care, and there was some evidence of improved outcomes by nurse prescribers outside the UK. In reviewing 72 RCTs of interventions to control blood pressure in patients with hypertension, <a href="./references#CD011227-bbs2-0179" title="GlynnLG , MurphyAW , SmithSM , SchroederK , FaheyT . Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD005182.pub4] ">Glynn 2010</a> included 12 studies of nurse‐led or pharmacist‐led care to improve blood pressure control. While the results were significantly heterogeneous, the effects were favourable and warranted further investigation in larger trials. The Hypertension Detection and Follow‐Up study was cited for providing evidence of the importance of a multifaceted intervention in blood pressure control, which consisted of an organised system of regular review and vigorous antihypertensive drug therapy (<a href="./references#CD011227-bbs2-0187" title="Hypertension Detection and Follow‐up Program Cooperative Group. Therapeutic control of blood pressure in the Hypertension Detection and Follow‐up Program. Hypertension Detection and Follow‐up Program Cooperative Group. Preventive Medicine1979;8(1):2‐13. ">Hypertension 1979</a>). </p> <p>In chronic disease management, nurses successfully titrated medications by protocol for diabetes, hypertension, and hyperlipidaemia within a team approach.There were limited descriptions of the interventions and protocols used for studies in the meta‐analysis (<a href="./references#CD011227-bbs2-0203" title="ShawRJ , McDuffieJR , HendrixCC , EdieA , Lindsey‐DavisL , NagiA , et al. Effects of nurse‐managed protocols in the outpatient management of adults with chronic conditions. Annals of Internal Medicine2014;161:113‐21. [DOI: 10.7326/M13‐2567] ">Shaw 2014</a>). <a href="./references#CD011227-bbs2-0181" title="GreerN , BolducJ , GeurkinkE , RectorT , OlsonK , KoellerE , et al. Pharmacist‐led chronic disease management: A systematic review of effectiveness and harms compared with usual care. Annals of Internal Medicine 2016 Apr 26 [Epub ahead of print]. [DOI: 10.7326/M15‐3058] ">Greer 2016</a> found pharmacist‐led chronic disease management was similar to usual care for resource use, and may improve goals for glycaemia, blood pressure, and cholesterol, but there is uncertainty whether clinical outcomes are improved. </p> <p>In a review of the effects of pharmacist‐provided non‐dispensing services on patient outcomes, health service utilisation, and costs in low‐ and middle‐income countries, <a href="./references#CD011227-bbs2-0198" title="PandeS , HillerJE , NkansahN , BeroL . The effect of pharmacist‐provided non‐dispensing services on patient outcomes, health service utilisation and costs in low‐ and middle‐income countries. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD010398] ">Pande 2013</a> reported on the outcomes of pharmacist interventions that involved counselling, education, and advice. There were small improvements in clinical outcomes (blood pressure, blood glucose, lipids, peak expiratory flow) and quality of life scores, however, the certainty of the evidence was graded as low. Health service utilisation and medication costs were reduced, but again the certainty of the evidence was graded as low. In a review of the effect of outpatient pharmacists' non‐dispensing roles on patient outcomes and prescribing patterns, <a href="./references#CD011227-bbs2-0195" title="NkansahN , MostovetskyO , YuC , ChhengT , BeneyJ , BondCM , et al. Effect of outpatient pharmacists' non‐dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews2010, Issue 7. [DOI: 10.1002/14651858.CD000336.pub2] ">Nkansah 2010</a> found that most of the 43 studies included in their review supported the role of pharmacists in medication/therapeutic management as one of a number of interventions to improve clinical outcomes. </p> <p>It is often difficult to distinguish the specific outcomes of non‐medical prescribing in reported studies and reviews, and the degree of influence on prescribing by physicians where team care arrangements exist. <a href="./references#CD011227-bbs2-0174" title="DriscollA , CurreyJ , TonkinA , KrumH . Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD009889.pub2] ">Driscoll 2015</a>, in a review of nurse‐led titration of drug therapy for people with heart failure, found that participants in the nurse‐led group were less likely to be admitted to hospital or to die. More participants reached the maximum drug dose in the nurse‐led group compared to titration of doses by primary care physicians. However we assessed a high level of autonomy in prescribing in only one of the seven reported studies (<a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a>). </p> <p>In a review of substitution of doctors by nurses in primary care, <a href="./references#CD011227-bbs2-0190" title="LaurantM , ReevesD , HermensR , BraspenningJ , GrolR , SibbaldB . Substitution of doctors by nurses in primary care. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD001271.pub2] ">Laurant 2005</a> found that the quality of care and health outcomes are similar for nurses and doctors, but it is not known if nurse substitution decreases doctors' workload. Nurses tended to provide more health advice and achieve higher levels of patient satisfaction compared to doctors. Nurses' higher use of resources, for example, ordering more tests, may offset savings in lower salary costs. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011227-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011227-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011227-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.2 Systolic blood pressure mmHg." data-id="CD011227-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.2 Systolic blood pressure mmHg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.1 HbA1c (%)." data-id="CD011227-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.1 HbA1c (%). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.3 Low‐density lipoprotein (LDL) mmol/L." data-id="CD011227-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Non‐medical prescribing group versus usual care, Outcome: 1.3 Low‐density lipoprotein (LDL) mmol/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 1 Systolic blood pressure mmHg." data-id="CD011227-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 1 Systolic blood pressure mmHg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 2 HbA1c (%)." data-id="CD011227-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 2 HbA1c (%).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 3 Low‐density lipoprotein (LDL) mmol/L." data-id="CD011227-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 3 Low‐density lipoprotein (LDL) mmol/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 4 Low‐density lipoprotein pharmacist vs nurse 6 mths." data-id="CD011227-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 4 Low‐density lipoprotein pharmacist vs nurse 6 mths. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 5 Adherence (continuous)." data-id="CD011227-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 5 Adherence (continuous). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 6 Adherence (dichotomous)." data-id="CD011227-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 6 Adherence (dichotomous). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 7 Health‐related quality of life." data-id="CD011227-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 7 Health‐related quality of life. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011227-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/urn:x-wiley:14651858:media:CD011227:CD011227-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_t/tCD011227-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Non‐medical prescribing group versus usual care, Outcome 8 Health facility resource use." data-id="CD011227-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Non‐medical prescribing group versus usual care, Outcome 8 Health facility resource use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/media/CDSR/CD011227/image_n/nCD011227-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011227-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Non‐medical prescribing compared to medical prescribing for acute and chronic disease management in primary and secondary care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Non‐medical prescribing compared to medical prescribing for acute and chronic disease management in primary and secondary care</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute and chronic disease<br/> <b>Settings:</b> secondary care and ambulatory/primary care in low‐, middle‐ and high‐income counties<br/> <b>Intervention:</b> non‐medical prescribing<br/> <b>Comparison:</b> medical prescribing </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Medical prescribing</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Non‐medical prescribing</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure (mmHg) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure in the control group ranged from 124 mmHg to 149 mmHg </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure in the intervention group was 5.31 mmHg lower (‐6.46 lower to ‐4.16 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4229<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b> <br/> <sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random‐effects analysis: MD ‐5.91 mmHg lower (95% CI ‐7.71 lower to ‐4.10 lower)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Glycated haemoglobin (HbA1c, %) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in glycated haemoglobin in the control group ranged from ‐0.90% to 9.7% </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in glycated haemoglobin in the intervention group was 0.62% lower (‐0.85 lower to ‐0.38 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>775<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random‐effects analysis:</p> <p>MD ‐0.62 (95% CI ‐0.85 to ‐0.38)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low‐density lipoprotein (mmol/L) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein in the control group ranged from ‐0.26 to 3.41 mmol/L</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein in the intervention group was 0.21 mmol/L lower (‐0.29 lower to ‐0.14 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1469<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random‐effects analysis: MD ‐0.30 (95% CI ‐0.62 to 0.02)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence (continuous)</p> <p>6 months follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adherence (continuous) in the control group was 0.79</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adherence in the intervention group was 0.15 higher (0.00 higher to 0.30 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>700<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Patient satisfaction was reported in 14 studies (<a href="#CD011227-tbl-0005">Table 4</a>). The majority of surveys were either not referenced or developed locally. Validated questionnaires assessing overall non‐medical practitioner satisfaction with care were reported in six studies rather than patient satisfaction with prescribing. An exception was the study by <a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a>, which found for the prescribing intervention, patients were generally positive about the pharmacist prescribing service, 85% (39/46) were totally satisfied, while 9% (4/44) would have preferred to see their GP </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7514</p> <p>(14 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>8,9</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>There was little or no difference in adverse events between treatment groups in nine studies. Two studies reported higher rates of adverse events in the usual care group. It was difficult to determine effects in the remaining studies because limited data were reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18,400</p> <p>(18 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life measured with SF‐12/36</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health‐related quality of life in the control group was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health‐related quality of life in the intervention group:</p> <p>physical component was 1.17 higher (0.16 to 2.17)</p> <p>mental component was 0.58 higher (‐0.40 to 1.55)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4631<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>Moderate</b><sup>10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>GP</b> : general practitioner; <b>MD</b> : mean difference; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to serious inconsistency (considerable heterogeneity was found).<br/> <sup>2</sup>Multifaceted interventions.<br/> <sup>3</sup>Variable prescribing autonomy.<br/> <sup>4</sup>Downgraded one level due to serious risk of bias (high risk of performance bias).<br/> <sup>5</sup>Variable reporting measures of adherence.<br/> <sup>6</sup>Downgraded one level due to indirectness (range of adverse events; may not be related to the intervention).<br/> <sup>7</sup>Downgraded one level due to selective outcome reporting (adverse events not reported in many studies).<br/> <sup>8</sup>Downgraded one level due to indirectness (prescribing component not adequately assessed across studies).<br/> <sup>9</sup>Variability in satisfaction measures.<br/> <sup>10</sup>Downgraded one level due to indirectness (prescribing component effect on quality of life difficult to determine). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Non‐medical prescribing compared to medical prescribing for acute and chronic disease management in primary and secondary care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Fixed‐effect outcomes versus random‐effects for clinical surrogate markers</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome or subgroup</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed‐effect estimate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random‐effects estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 Systolic blood pressure (mmHg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.85 (‐6.76 to ‐4.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.59 (‐8.48 to ‐4.71)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.76 (‐8.24 to ‐5.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐7.34 (‐11.09 to ‐3.60)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.31 (‐6.46 to ‐4.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐5.91 (‐7.71 to ‐4.10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 HbA1c (%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.55 (‐0.74 to ‐0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.55 (‐0.76 to ‐0.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2.1 HbA1c (6 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.42 (‐0.75 to ‐0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.45 (‐0.09 to ‐0.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2.2 HbA1c (12 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.62 (‐0.85 to ‐0.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.62 (‐0.85 to ‐0.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3 LDL (mmol/L)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.23 (‐0.28 to ‐0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.22 (‐0.42 to ‐0.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3.1 LDL (6 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.25 (‐0.34 to ‐0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.13 (‐0.39 to 0.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3.2 LDL (12 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.21 (‐0.29 to ‐0.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.3 (‐0.62 to 0.02)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>LDL: low‐density lipoprotein</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Fixed‐effect outcomes versus random‐effects for clinical surrogate markers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcomes of studies not included in meta‐analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patient group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To compare the effectiveness of pharmacist medication review with or without pharmacist prescribing with standard care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compared with baseline the Chronic Pain Grade improved in prescribing arm 47.7% (21/44; P = 0.003) and review arm 38.6% (17/44; P = 0.001) but not TAU 31.3% (15/48; ns) SF‐12 mental component score showed no effect for prescribing or review arms and deterioration in TAU arm. Hospital Anxiety and Depression scores improved in prescribing arm for depression (P = 0.022) and anxiety (P = 0.007) and between groups (P = 0.022 and P = 0.045 respectively). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anticoagulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacist versus physician independent management of anticoagulant therapy for inpatients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no differences between groups for mean heparin and warfarin doses, partial thromboplastin time, days to reach therapeutic levels, mean prescribed and simulated heparin doses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type 2 diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacist case management versus usual medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the pharmacist case managed group received greater reductions in HbA1c (2.1% vs 0.9%, P = 0.03). Three of five process measures were conducted more frequently in the intervention group than control group. LDL measurement (100% vs 85.7%, P = 0.02), retinal examination (97.3% vs 74.3%, P = 0.004), monofilament foot screening, (92.3% vs 62.9%, P = 0.002). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Family planning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Family planning services provided by nurses versus physicians</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurses' clients were as equally as successful as physicians in continuing contraceptive use and preventing pregnancy. Nurses were less likely than physicians to provide patients on their first visit with IUDs, prescribe oral contraceptives, or sterilisation. Nurses were more likely to give temporary prescriptions than physicians until the next visit (25% vs 16%, P &lt; 0.001) for reasons including possible pregnancy and patients not menstruating. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0012" title="EllisSL , CarterBL , MaloneDC , BillupsSJ , OkanoGJ , ValuckRJ , et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy2000;20(12):1508‐16. ">Ellis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dyslipidaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pharmacists providing pharmaceutical care in addition to usual medical care versus usual medical care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The absolute change in total cholesterol (17.7 vs 7.4 mg/dL, P = 0.028) and LDL (23.4 vs 12.8 mg/dL, P = 0.042) was greater in the intervention than control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prescribing of antiretroviral treatment by nurses versus doctors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort 1 ‐ not receiving antiretrovirals. Time to death did not differ (HR 0.94, 95% CI 0.76 to1.15). </p> <p>Cohort 2 ‐ received antiretrovirals for at least six months. Viral load suppression 12 months after enrolment was equivalent in intervention and control. Risk difference 1.1% (95% CI ‐2.4 to 4.6). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Collaborative care model of clinical pharmacists providing drug therapy management and treatment follow‐up versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical improvements noted in both groups but not significant. Intervention group had higher drug adherence at six months (67% vs 48%; OR 2.17, 95% CI 1.04 to 4.51; P = 0.038) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0015" title="FischerHH , EisertSL , EverhartRM , DurfeeMJ , MooreSL , SoriaS , et al. Nurse‐run, telephone‐based outreach to improve lipids in people with diabetes. American Journal of Managed Care2012;18(2):77‐84. ">Fischer 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lipid control in diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Algorithm‐driven telephone care by nurses as an adjunct to usual care versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The percentage of patients with an LDL &lt; 100 mg/dL increased from 52% to 58.5% in the intervention group and decreased from 55.6% to 46.7% in the control group (P &lt; 0.01). The intervention did not affect glycaemic and BP outcomes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood pressure control in diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A pharmacist‐led intervention (Adherence and Intensification of Medications) in patients with diabetes and poor BP control versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean systolic BP decrease from 6 months before to 6 months after the 14‐month intervention was not different (8.9 mmHg decline in the intervention arm and 9.0 mmHg decline in the control arm). There was no difference in the mean HbA1c and LDL levels between groups after the end of the intervention period (examining 12 months). At the end of the first quarter after activation, there was a significantly greater drop in systolic BP in the intervention group versus control, 9.7 mmHg vs 7.2 mmHg; MD 2.4 mmHg (95% CI 1.5 to 3.4 P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type 2 diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary care nurse management of type two diabetes versus management by GPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>After 14 months between‐group differences for reduction in HbA1c, BP, and lipid profile were not significant. Mean systolic and diastolic BPs were lower in both groups. Most process indicators were significantly better in the nurse care group. More patients were satisfied with their care in the nurse group however the physical component of the SF‐26 was better in the GP group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular risk factors in diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurse case management versus usual care to improve hypertension, hyperglycaemia, and hyperlipidaemia in veterans with diabetes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A greater number of patients in the nurse case management had all three measures under control (21.9% vs 10.1%, P &lt; 0.01). A greater number of intervention group participants achieved individual treatment goals. HbA1c &lt; 8% (73.7% vs 65.8% P = 0.04), BP &lt; 130/80 mmHg (45% versus 25.4%, P &lt; 0.01) but not for LDL &lt; 100 mg/dL (57.6% vs 55.4%, P = 0.61). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐insulin dependent diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacists providing pharmaceutical care versus physicians</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement was seen in glycated haemoglobin in the intervention group at 4 months (9.2% ± 2.1 vs 12.1% ± 3.7, P = 0.003), and fasting plasma glucose (8.5 ± 2.3 vs 11.0 ± 3.9 mmol/L, P = 0.015). There was little or no change within or between groups for BP, lipid profile, renal function, weight, or quality of life measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with signs of incomplete abortion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Midwives diagnosing and treating incomplete abortion with misoprostol compared to physicians </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>452 (95.8%) women in the midwife group and 467 (96.7%) in the physician group had complete abortion. The model risk difference for midwife versus physician group was ‐0.8% (95% CI ‐2.9 to 1.4) falling within the predefined equivalence range (‐4% to 4%). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐inferiority of care provided by a hospital‐based specialised asthma nurse versus a GP or paediatrician </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The corrected daily dose of inhaled corticosteroids as well as the percentage of children prescribed long‐acting beta agonists/inhaled corticosteroids was not significantly different between groups at one and two years. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment of hypertension in the workplace by nurses versus treatment in the community by the family doctor </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the nurse group were more likely to be put on antihypertensive medications (94.7% vs 62.7%, P &lt; 0.001), to reach goal BP in the first six months (48.5 vs 27.5%, P &lt; 0.001) and to take drugs prescribed (67.6 vs 49.1%, P &lt; 0.005). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0032" title="MarottiSB , KerridgeRK , GrimerMD . A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesthesia and Intensive Care2011;39(6):1064‐70. ">Marotti 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacist medication history and supplementary prescribing versus pharmacist medication history versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The marginal mean number of missed doses per patient was 3.21 (95% CI 2.89 to 3.52) in the control group, which was reduced in the pharmacist prescribing group 1.07 (95% CI 0.90 to 1.25, P = 0.002) but not in the pharmacist history group 3.30 (95% CI 2.98 to 3.63). The number of medications charted at an incorrect dose or frequency was reduced in the pharmacist history group. The pharmacist prescribing group had less dose errors than the pharmacist history group (P = 0.004). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary prevention of coronary heart disease in primary care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Audit group verus GP recall group versus nurse recall group (disease register and patient recall to nurse‐led clinic) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference occurred in assessment between the nurse and GP recall group. Mean BP, total cholesterol, cotinine levels varied little between groups as did prescribing of hypotensive and lipid‐lowering agents. Prescribing of antiplatelet drugs was higher in the nurse recall group vs GP recall group, MD 8% (95% CI 1% to 15%, P = 0 .031). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary care nurses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Education and implementation of prescribing and clinical guidelines by nurses in rural health centres versus usual nurse care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antibiotic prescribing in children 0 to 5 years for respiratory tract infections fell, (42% at baseline to 27% at follow‐up, control 27% to 30%, P = 0.022). Guidelines had no effect on prescribing antibiotics for diarrhoea but oral rehydration prescribing increased. Diazepam prescribing for adults fell, (intervention 17% to 10%, control 21% to 18%, P = 0.029). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients attending primary care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurse practitioners versus physicians plus conventional nurse in primary care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Similar mortality experience, no differences in physical functioning capacity, social or emotional function. Quality of care similar. In 510 prescriptions, an adequate rating was given to 75% of conventional group and 71% in the nurse practitioner group, probably leading to little difference between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type 2 diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A pharmacist‐led Veterans affairs Multidisciplinary Education and Diabetes Intervention for Cardiac risk reduction (VA‐MEDIC) plus usual care versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>After four months there was a difference (P &lt; 0.05) in the percentage of VA‐MEDIC patients versus controls in attaining target goals for systolic BP &lt; 130 mmHg and HbA1c &lt; 7% but not lipid control or tobacco use. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug therapy in a geriatric setting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug therapy prescribing and patient care management by clinical pharmacists versus usual care </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The clinical pharmacist group probably had a lower number of deaths (P = 0.05), a higher number of patients being discharged to lower levels of care (P = 0.03) and a lower average number of drugs per patient (P = 0.04). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0044" title="TsuyukiRT , Al HamarnehYN , JonesCA , HemmelgarnBR . The effectiveness of pharmacist interventions on cardiovascular risk. The multicenter randomized controlled RxEACH trial. Journal of the American College of Cardiology2016;67(24):2846‐54. ">Tsuyuki 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients with cardiovascular risk factors associated with hypertension, diabetes, dyslipidaemia and smoking </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community pharmacist care versus usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 3 months the intervention group patients had greater improvements in LDL cholesterol (‐ 0.2 mmol/L, P &lt; 0.001, systolic BP (‐9.37 mmHg, P &lt; 0.001), glycosylated haemoglobin (‐0.92%, P &lt; 0.001) and smoking cessation (20.2%, P &lt; 0.002). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>BP: blood pressure<br/> CI: confidence interval<br/> GP: general practitioner<br/> HbA1c: glycated haemoglobin<br/> HR: hazard ratio<br/> IUD: inter uterine device<br/> LDL: low‐density lipoprotein<br/> MD: mean difference<br/> OR: odds ratio<br/> TAU: treatment as usual </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcomes of studies not included in meta‐analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Primary outcome ‐ medication adherence</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Medication adherence measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morisky Medication Adherence<br/> Scale </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed adherence at baseline with patients in both groups reporting full adherence.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication possession ratios</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The medication possession ratio (total days' supply of medication divided by total number of expected medication intake days) used in this study found little or no difference between the pharmacist prescribing arm and usual care, even though more medications were prescribed in the pharmacist arm. Adherence was high and ranked above 80%. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication possession ratios</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Determined the medication possession ratio from computerised prescription refill records. Full drug adherence was defined as a medication possession ratio value of 0.83 or more during the six‐month follow‐up. Medication possession ratios at three and six months were probably not different between intervention and control arms even though patients in the intervention group were more likely to change antidepressants. An additional measure, the Health Plan Employer Data Information Set guidelines for successful antidepressant treatment, showed there was little or no difference between groups in compliance with the early phase of treatment, but there was a significant difference in compliance in the intervention group continuation phase. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morisky Medication Adherence</p> <p>Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported no differences at study end in the proportions of subjects reporting high medication adherence. There was an improvement in adherence with the groups from baseline to study end. Adherence did not predict goal attainment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐adherence was identified in five of 33 patients with drug therapy problems at baseline, one of 12 patients at six months and one of four patients at nine months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient claim and pill counts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High adherence was judged if patients claimed to be taking their medication as instructed and 80% or more of drugs prescribed were consumed as determined by pill counts. In the nurse intervention group patients were more adherent than the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medication possession ratios</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Little or no difference between groups in the mean medication possession ratio adherence score over the six‐month study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morisky Medication Adherence</p> <p>Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported adherence measured by the Morisky scale modified for blood pressure medications.</p> <p>Adherence to antihypertensive medications at six months increased in the pharmacist intervention telemonitoring group but decreased in the usual care group. There was probably no difference between groups at 12 and 18 months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electronic drug event monitor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The drug event monitor provided the average number of days on which patients took the correct number of doses prescribed. While adherence was high in both groups, the nurse‐managed patient group had higher adherence than usual care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient self‐reporting and drug refill information from the pharmacy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐adherence was judged as missing more than three doses a week or pharmacy records indicated a failure to refill drugs within two weeks after the scheduled refill date. Little or no difference in adherence between or within the two groups at baseline or the end of the study was found. Over 90% of patients in both groups indicated they took their drugs as directed. The study was underpowered to detect a significant difference in adherence. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Primary outcome ‐ medication adherence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Secondary outcomes ‐ patient and provider satisfaction</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Satisfaction tool measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19/57 respondents stated that the nurse care management programme was moderately helpful.</p> <p>32/57 found it extremely helpful.</p> <p>9/13 physicians with two or more patients recommended adoption of the nurse management programme. </p> <p>In other health care settings: 9 physicians felt the programme decreased their time with patients, while 4 thought it increased the time spent. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 patient satisfaction statements derived from a local prescribing feasibility study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For the prescribing intervention, patients were generally positive about the pharmacist prescribing service ‐ 85% (39/46) were totally satisfied, while 9% (4/44) would have preferred to see their GP. In semi‐structured interviews with GPs and pharmacists, all pharmacists and most GPs were positive about the intervention. Pharmacists found their role satisfying, interesting, and challenging. 17 of 23 GPs were positive about the pharmacists’ role. The cost‐effectiveness of the pharmacists' role, given limited resources, was one issue raised in the GP focus group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients reported greater treatment satisfaction with the collaborative care model than the control group in 6 of 11 measures including the overall treatment for depression, personal nature of the care, listening to concerns, explanations about why antidepressants were prescribed and how to take them, availability for advice, and overall satisfaction with the organisation. </p> <p>18/37 primary care provider questionnaire respondents were satisfied with workflow, patient welfare. and the pharmacists' abilities. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Evaluation of the Quality of Diabetes Care (PEQD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients' evaluations of their satisfaction with diabetes care from the specialist diabetes nurse were significantly more positive than the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Evaluation of the Quality of Diabetes Care (PEQD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total satisfaction sum score for 14 PEQD measures for practice nurses was 66.4%, compared to 51.7% in the GP group which may be confounded by the amount of time given to each patient. On average GPs spent a total of 28 minutes per patient, whereas practice nurses spent 128 minutes per patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfation in the SF‐36 healthcare domain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with hypertension care was high in both groups, but with little or no difference in any of the 11 satisfaction measures. Satisfaction was not associated with blood pressure goal attainment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22‐item Pharmacist Service Questionnaire.</p> <p>0‐100 scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction with the clinical pharmacist were high, with mean scores 92.4 (±10.9) at 6 months (n = 49) and 92.7 (±11) at 9 months (n = 44). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Satisfaction Questionaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvements in four areas of satisfaction in the intervention group linked to an increased time spent with patients and an emphasis on patient‐centred education and self‐management (i.e. quality and quantity of contact) from base line to study end. Between‐group comparisons at study end demonstrated little or no significant difference in patient satisfaction measures, including overall care and general satisfaction. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6% of patients were dissatisfied with care provided by nurses but details of the survey instrument were not provided: (assumed 12/206 intervention patients at 6 months but not specified). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in overall health care satisfaction between pharmacist‐ and nurse‐led care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients at 6 months reporting they were very or completely satisfied with their hypertension care was probably higher in the intervention group than the usual care group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Six items from the Consumer Assessment of Healthcare Providers and Systems adult survey (version 4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction items concerning clinicians listening carefully, explaining things clearly, and respecting what patients said showed larger improvements amongst patients in the telemonitoring intervention group than usual care at 6 months but not at 12 or 18 months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96% of patients in the nurse practitioner group and 97% of patients in the conventional care group were satisfied with the health services received in the experimental period. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no significant differences in patient satisfaction between groups. More patients in the intervention group felt that the pharmacist spent more time with them than did control patients, although there was little difference. There was no difference in satisfaction with pharmacy services or changes in patient satisfaction in either group from baseline to study end. This study was underpowered to detect a significant difference in patient satisfaction. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>GP: general practitioner</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Secondary outcomes ‐ patient and provider satisfaction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Primary outcome ‐ adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the proportions of patients between control (provider education), nurse facilitator and provider/patient notification for hospitalisations and emergency room visits. There were few deaths with the higher number (7) in the control group which had more patients on haemodialysis, two of whom died. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There appeared little or no difference between intervention and usual care groups for severe low blood glucose events at baseline and during the study period. Mean weight gain differences from insulin treatment in each group or mean weight loss differences with oral agents showed little or no difference. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported no patients had major bleeding, but four patients in the pharmacist prescriber group had minor bleeding (one laceration before hospital). One patient in physician prescriber group died, after receiving heparin and warfarin for a stroke in evolution but there was no evidence of bleeding. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The first year mortality was 3.4% in usual care and 4.1% in the intervention group. However, a longer study is required to show a difference, namely, 2 years plus a 5‐ to 10‐year follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The time to death did not differ between primary care nurses and doctors initiating therapy. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pharmacists identified two adverse drug reactions from 33 drug therapy problems at baseline, two from 12 at six months and none at nine months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events were similar between groups, with no participants withdrawing from the study due to an adverse event, and there was no difference in the rate of hospitalisation or death between the groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported 17 hypoglycaemic reactions in the intervention group and two in the control group. All were considered mild to moderate. The difference was possibly related to increased training in recognition, documentation, and questioning in the intervention group. Three patients were hospitalised, two in the control and one in the intervention group, and these appear unrelated to treatment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0025" title="Klingberg‐AllvinM , CleeveA , AtuhairweS , TumwesigyeNM , FaxelidE , ByamugishaJ , et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet2015;385:2392‐8. ">Klingberg‐Allvin 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In treating incomplete abortion bleeding, the same or less than normal menstrual cycle was probably not different between the intervention midwife and usual care physician groups. There was little difference in pain after treatment as assessed by a visual analogue scale. 30 (6%) of women reported unscheduled visits in the midwife group and 18 (4%) in the physician group. Reasons included vaginal bleeding and abdominal pain. Reported side‐effects after treatment were similar in both groups (nausea, vomiting, abdominal pain, chills, and fever). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no differences between groups (general practitioner, paediatrician, asthma nurse) with respect to the number of severe asthma exacerbations as expressed by the number of prednisolone courses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forty drug‐related adverse events occurred in the intensive intervention group as compared to 10 in the standard group. While the adverse events are known for the drugs in question no further comment was offered. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported few clinical events at six months in a pharmacist‐led intervention for secondary prevention after ischaemic stroke. There were nine cardiovascular events and no deaths in the pharmacist group versus eight cardiovascular events and one death in the nurse‐led group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were 60 adverse events in usual care and 49 in the telemonitoring group; most events were non‐cardiac hospitalisations. There were two allergic reactions to blood pressure medication in the usual care group, six events in the telemonitoring group related to hypotension, dizziness, loss of consciousness which compared to one in the usual care group, four events in usual care related to hypertension versus one in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0035" title="NewJP , MasonJM , FreemantleN , TeasdaleS , WongLM , BruceNJ , et al. Specialist nurse‐led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care2003;26:2250‐5. ">New 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In patients randomised to specialist nurse‐led clinics for blood pressure control, lipid control or both, there were less deaths in the intervention group (25, (3.2%) versus 36 (5.7%) in the usual care group) odds ratio 0.55 (95% confidence interval 0.32 to 0.92) P = 0.02. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>During the 12‐month experimental period, there were four deaths in the nurse practitioner group and 18 in the conventional care group. There was probably little or no difference in the crude death rate between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no diabetes‐related admissions or deaths for either group during the six‐month study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pharmacist prescribing group in a geriatric setting may have had a slightly lower 12‐month mortality than usual care (3/67 versus 10/72, P = 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0042" title="TobeS , PylypchukG , WentworthJ , KissA , SzalaiJP , PerkinsN , et al. Effect of nurse‐directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomised controlled trial. Canadian Medical Association Journal2006;174(9):1267‐71. ">Tobe 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The incidence of adverse events probably did not differ between the intervention (home care nurse group) and control (primary care physician group) in First Nations people with diabetes and hypertension. Ten patients in the intervention group and seven in the control group required admission to hospital for adverse events. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Primary outcome ‐ adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Secondary outcome ‐ quality of life</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four generic quality of life measures from the</p> <p>Behavioural Risk Factor Surveillance System</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention and control groups reported improved perception of health status after 12 months, but intervention patients were twice as likely to report this. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36, the Duke Activity Status Index for QoL, and the BDI for depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences for any of the variables, but an improved mood for both groups was found. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0005" title="BruhnH , BondCM , ElliottAM , HannafordPC , LeeAJ , McNameeP , et al. Pharmacist‐led management of chronic pain in primary care: Results from a randomised controlled exploratory trial. BMJ Open2013;3:2013. ">Bruhn 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐12, HUI, CPG, and HADS‐D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No one measure was seen as the primary outcome. In the prescribing arm there was a within‐arm improvement for CPG intensity and disability effect size subscales and between arms on the intensity subscale but not the disability subscale. There was a within‐arm improvement in overall CPG in the prescribing and review arms but not the TAU arm. The SF‐12 and HADS‐D showed deterioration in the TAU arm. Compared with baseline, patients had an improved CPG in the prescribing and review arms but not the TAU arm. The SF‐12 physical score difference showed no effect in prescribing or review arms but improvement in the TAU arm. SF‐12 mental score showed no effect in prescribing or review arms and deterioration in the TAU arm. HADS‐D scores within the prescribing arm showed improvement for depression and anxiety which were also significant between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 for Veterans</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no change in quality of life scores over 6 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Brief Inventory for depressive symptoms and Work and Social Disability Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Liitle or no difference at 6 months between intervention and control groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 and the revised version of the Type 2 Diabetes Symptom Checklist to measure the presence and perceived burden of diabetes‐related symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences over 12 months between groups in either survey.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 and the revised version of the Type 2 Diabetes Symptom Checklist to measure the presence and perceived burden of diabetes‐related symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the control group there were little or no differences between baseline and follow‐up SF‐36 measures, however in the practice nurse intervention group there were differences in physical functioning, role physical, vitality, and the physical component score. Little or no differences were seen in the QoL results over time between the two groups except for the physical component score which was lower in the intervention group. After 14 months responses to the revised Type 2 Diabetes Symptom Checklist revealed little or no differences between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference except in the general health domain with scores higher in the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0023" title="JaberLA , HalapyH , FernetM , TummalapalliS , DiwakaranH . Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy1996;30:238‐43. ">Jaber 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health Status Questionnaire version 2 derived from the SF‐36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference between or within groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0024" title="KhuntiK , StoneM , PaulS , BainesJ , GisborneL , FarooqiA , et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart2007;93:1398‐405. ">Khunti 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36, Seattle Angina Questionnaire and LVD‐36 questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Differences favouring the intervention group were found in the SF‐36 for physical functioning, general health, vitality, social functioning, and mental health. Seattle Angina Questionnaire scores in patients with angina were significantly better for intervention patients compared to controls for exertional capacity and borderline differences were found for angina frequency and QoL. There was little or no difference in any of the SF‐36 health status domains or LVD‐36 scores for patients with a confirmed diagnosis of left ventricular diastolic dysfunction. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐12</p> <p>Diabetes Quality of Life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference between groups in either measure at study end.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐related health using a Likert scale</p> <p>The EQ‐5D as an index of health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference between the pharmacist‐ and nurse‐led groups in participants overall self‐related health. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences between groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dartmouth COOP charts EuroQol scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no or clinically important differences between groups for any dimension.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the nurse practitioner and usual care groups had similar values at baseline and study end for physical, emotional, and social function. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change from baseline in depression symptoms by the PHQ‐9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Even though no pharmacologic treatments for depression symptoms were offered as part of the intervention, the mean change in PHQ‐9 scores was probably not different for intervention and standard care participants. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no significant differences either between or within the two groups from baseline to study end, although patients in the control group reported more bodily pain . </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>BDI: Beck Depression Index<br/> CPG: Chronic Pain Grade<br/> EQ‐5D: EuroQol five dimensions questionnaire<br/> HADS‐D: Hospital Anxiety and Depression Scale<br/> HUI: Health Utilities Index<br/> LVD‐36: Left Ventricular Dysfunction<br/> PHQ‐9: Patient Health Questionnaire‐9<br/> QoL: quality of life<br/> SF‐12: Short‐Form‐12<br/> SF‐36: Short‐Form‐36<br/> TAU: treatment as usual </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Secondary outcome ‐ quality of life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011227-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Secondary outcome ‐ resource use</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Medication and related therapy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Outcome</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>β‐blocker use was higher in the nurse facilitator group with two‐thirds of patients either initiated or up‐titrated on β‐blockers versus fewer than one‐third of patients in the other two study arms (control provider education and provider/patient notification). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0006" title="ChenellaFC , KlotzTA , GillMA , KernJW , McGhanWF , PaulsonYJ , et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. American Journal of Hospital Pharmacy1983;40:1642‐5. ">Chenella 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in amount of anticoagulant drugs prescribed by pharmacists compared to a physician. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More patients in the pharmacist prescribing arm were prescribed diuretics and sulphonylureas compared to usual care. Overall there was an increase in the number of medications prescribed by pharmacists for hypertension, diabetes, and cholesterol from baseline to six months, but little or no change in the usual care arm. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0010" title="DenverEA , BarnardM , WoolfsonRG , EarleKA . Management of uncontrolled hypertension in a nurse‐led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care2003;26:2256‐60. ">Denver 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In nurse‐led clinic for hypertension management in diabetics at six months there were increased changes in the proportions of patients receiving new prescriptions for calcium channel blockers and thiazide diuretics as intensification therapy. The median number of drugs per patient increased in the intervention group compared to conventional primary care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0011" title="EinhornRF , TriasM . Differences between physicians and nurses in providing family planning services: Findings from a Bogota clinic. Studies in Family Planning1978;9(2):35‐8. ">Einhorn 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In a family medicine clinic in Bogota, nurses were less likely than physicians to provide intrauterine devices, prescribe oral contraceptives, and sterilisation on the patient's first visit. Nurses were more likely than physicians to provide temporary prescriptions and defer intrauterine devices and contraceptive measures if the patient on their first visit was not menstruating or believed to be pregnant. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational cohort results taken six months following the quarter start date showed intervention patients had more blood pressure medication changes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacists identified at least one hypertension drug therapy problem in 33/73 (45.2%) patients at baseline requiring additional therapy in 14/33 (42.4%) and dosage increases in 11/33 (33.3%). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The nurse specialist in diabetes prescribed significantly more antihypertensive agents and the internist (doctor control) prescribed more cholesterol‐lowering agents. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean number of antihypertensive medications per patient and use of generic antihypertensive agents was higher in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0028" title="LoganAG , MilneBJ , AchberC , CampbellWP , HaynesRB . Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet1979;2:1175‐8. ">Logan 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients in the nurse‐managed group were more likely to be put on antihypertensive medications, prescribed more than two pills per day, and to be on more than one antihypertensive medication. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0029" title="MacMahon ToneJ , AghaA , SherlockM , FinucaneF , TormeyW , ThompsonCJ . An intensive nurse‐led, multi‐interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. International Journal of Medical Science2009;178:179‐86. ">MacMahon Tone 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were more intervention intensive group patients on three or more antihypertensive drugs (at the study beginning more patients in the standard care group were on three or more antihypertensive agents). At the end of the study more patients with dyslipidaemia in the intensive group were receiving statin therapy. More patients in the intervention group were on aspirin antiplatelet therapy at the end of the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0033" title="McAlisterFA , MajumdarSR , PadwalRS , FradetteM , ThompsonA , BuckB , et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. Canadian Medical Association Journal2014;186:577‐84. ">McAlister 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The median number of antihypertensive medications taken at six months was probably not different in the pharmacist‐ and nurse‐led groups. There was a difference favouring pharmacists in maximal dosing of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers at six months, but not the percentage of patients using these drugs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In patients completing the six‐month visit, there were more intervention patients that had an antihypertensive medication added to their regimen and a dose increased for existing medication, than usual care patients. There was an increase in the usage of specific antihypertensive drugs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were increases in the mean number of antihypertensive medication classes at 6, 12, and 18 months in the intervention group compared to baseline and compared to usual care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0034" title="MoherM , YudkinP , WrightL , TurnerR , FullerA , SchofieldT , et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ2001;322:1‐7. ">Moher 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was minimal change in prescribing antihypertensive drugs in the three groups. All groups increased prescribing of lipid‐lowering drugs but there was little or no difference between groups. There was an increase of 10% more patients’ prescribed antiplatelet treatment in the nurse recall group versus the audit group and 8% more in the nurse recall group versus the general practitioner recall group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0036" title="PagaiyaN , GarnerP . Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health2005;10(5):471‐7. ">Pagaiya 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In examining the effects of training and guidelines on prescribing by nurses, the mean change in antibiotic prescribing for all patients showed little or no difference. The mean change for antibiotic prescribing for respiratory infections in children (0 to 5 years) fell. No change was detected in prescribing antibiotics for diarrhoea. There was a mean fall in diazepam prescribing in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0037" title="RuddR , Houston MillerN , KaufmanJ , KraemerHC , BanduraA , GreenwaldG , et al. Nurse management for hypertension. American Journal of Hypertension2004;17:921‐7. ">Rudd 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the nurse management patient group at six months there was an increased number and variety of antihypertensive medications and an increased number of medication changes than in the usual care group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0039" title="TaveiraT , FriedmannPD , CohenLB , DooleyAG , KhatanaSAM , PirragliaPA , et al. Pharmacist‐led group medical appointment model in type 2 diabetes. Diabetes Educator2010;36(1):109‐17. ">Taveira 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention arm group (VA‐MEDIC) had greater dose titrations of antihypertensive medications, insulin, statins, and niacin compared to the usual care arm. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention arm participants (VA‐MEDIC‐D) had more dose increases or initiation of any antihypertensive agents and more dose increases or initiation of antihyperglycaemic agents. There was little or no difference in the initiation or dose titration of any antihyperlipidaemic agent or antidepressants. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The average number of drugs prescribed per patient was lower in the pharmacist group compared to the physician group. The number of drugs was reduced by an average of 2.2 drugs per patient from the pre‐study to the study year. The practice of clinical pharmacists prescribing drug therapy under physician supervision has the potential to save the healthcare system USD 70,000 per 100 skilled nursing facility beds. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0043" title="TsuyukiRT , HouleSKD , CharroisTL , KolberMR , RosenthalMM , LewanczukR , et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. The Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132(2):93‐100. ">Tsuyuki 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the pharmacist prescribing arm proportionally more new antihypertensive agents were initiated, more dose changes occurred, more antihypertensives were discontinued, and more patients were prescribed low‐dose aspirin and a statin than in the usual care group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the type of antihypertensives prescribed to intervention and control patients during the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0046" title="WallymahmedME , MorganC , GillGV , MacFarlaneIA . Nurse‐led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance. Diabetic Medicine2011;28:373‐9. ">Wallymahmed 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compared with baseline there were more patients in both groups taking antihypertensive medications but this difference was probably only important in the nurse‐led intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Healthcare visits, health resources, and associated costs</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0001" title="AnsariM , ShlipakMG , HeidenreichPA , VanOstaeyenD , PohlEC , BrownerWS , et al. Improving guideline adherence. A randomized trial evaluating strategies to increase β‐blocker use in heart failure. Circulation2003;107(22):2799‐804. ">Ansari 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in hospitalisations and emergency room visits between the three groups of control (provider education), nurse facilitator, and provider/patient notification. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0002" title="AubertRE , HermanWH , WatersJ , MooreW , SuttonD , PetersonBL , et al. Nurse case management to improve glycaemic control in diabetic patients in a health maintenance organisation. Annals of Internal Medicine1998;29:605‐12. ">Aubert 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions were rare and did not differ between the intervention and usual care groups. ED visits did not differ between groups or from baseline. No hospital or ED visits were related to diabetes. The average number of outpatient visits during the study was similar. The nurse managed a case load of 71 patients, but it was estimated that a 300 patient case load could be managed. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0003" title="Barr TaylorC , Houston MillerN , ReillyKR , GreenwaldG , CunningD , DeeterA , et al. Evaluation of a nurse‐care management system to improve outcomes in patients with complicated diabetes. Diabetes Care2003;26:1058‐63. ">Barr Taylor 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no change in health utilisation (physician visits, ED visits, days of hospitalisation) for the year before and after the intervention and between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0007" title="ChoeHM , MitrovichS , DubayD , HaywardRA , KreinSL , VijanS . Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care2005;11:253‐60. ">Choe 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In reporting process measures for the clinical pharmacist’s case management of patients there was a difference between pharmacist intervention and control in the frequency of low‐density lipoprotein measurements, retinal examinations, and monofilament foot examinations but not glycated haemoglobin measurement or urine albumin screen. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0008" title="CohenLB , TaveiraTH , KhatanaSA , DooleyAG , PirragliaPA , WuWC . Pharmacist‐led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator2011;37:801‐12. ">Cohen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over six months there were a higher number of primary care visits in the usual care arm; an average 1.65 visits per patient versus 1.56 in the intervention arm. It was suggested the difference in the higher number of primary care visits may offset the intervention cost. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0009" title="DeBuskRF , Houston MillerN , SuperkoR , DennisCA , ThomasRJ , LewHT , et al. A case‐management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine1994;120:721‐9. ">DeBusk 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The nursing time spent in the year after myocardial infarction was nine hours per patient; a per patient cost of USD 500 which included the nurse salary, office costs, and other associated costs. This compared with cardiac rehabilitation programmes in the San Francisco Bay area costing USD 1800 to USD 2700 to participate for three months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0012" title="EllisSL , CarterBL , MaloneDC , BillupsSJ , OkanoGJ , ValuckRJ , et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy2000;20(12):1508‐16. ">Ellis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In investigating the impact of clinical pharmacist interventions in patients with dyslipidaemia there was little or no difference in physician or nurse visits between control and the intervention patients at 12 months. At 12 months the intervention group had more pharmacist visits than the control group. There were little or no difference in costs for hospitalisations, clinic visits, laboratory costs, drug costs, and costs of lipid therapy between groups. The intervention group had a USD 370 greater difference per patient in total costs which was probably not important and approximately 5% of total costs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0013" title="FairallL , BachmannMO , LombardC , TimmermanV , UebelK , ZwarensteinM , et al. Task shifting of antiretroviral treatment from doctors to primary‐care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster‐randomised trial. Lancet2012;380:889‐98. ">Fairall 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the cohort of patients not yet receiving antiretroviral therapy there was little or no difference in clinic visits with a nurse but clinic visits with a doctor were probably higher in the intervention group. </p> <p>In the cohort of patients who had already received at least six months of antiretroviral therapy clinic visits with a nurse probably higher in the intervention group. Economic data from the study is the subject of further analysis by <a href="./references#CD011227-bbs2-0159" title="BartonGR , FairallL , BachmannMO , UebelK , TimmermanV , LombardC , et al. Cost‐effectiveness of nurse‐led versus doctor‐led antiretroviral treatment in South Africa: pragmatic cluster randomised trial. Tropical Medicine and International Health2013;18(6):769‐77. ">Barton 2013</a> (see <a href="./references#CD011227-bbs1-0003" title="">Studies awaiting classification</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0014" title="FinleyPR , RensHR , PontJT , GessSL , LouieC , BullSA , et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy2003;23:1175‐85. ">Finley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Although the collaborative care model experienced a decrease in the total number of primary care visits, the between‐group difference was probably not important. ED visits increased more in the usual care group but this was probably not important and neither was the difference in utilisation of psychiatric services. The institutional cost of drugs, the cost of antidepressants and the cost of psychotropic drugs overall was higher in the intervention group, but this was not important. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0015" title="FischerHH , EisertSL , EverhartRM , DurfeeMJ , MooreSL , SoriaS , et al. Nurse‐run, telephone‐based outreach to improve lipids in people with diabetes. American Journal of Managed Care2012;18(2):77‐84. ">Fischer 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions (while trending to fewer admissions) in the nurse intervention group showed little or no difference to the control group. Nurse case management was not associated with a significant difference in the number of outpatient or ED visits. There was a decrease in total costs in the nurse telephone intervention group comparing the period before and after randomisation. In contrast, there was an increase for the same comparison in the control group. Similar results were seen with hospitalisation and ED costs which were lower in the intervention group. There was probably not an intervention effect on outpatient costs. The difference in average per patient cost between the intervention group (USD 6600) and control group (USD 9033) of USD 2433 was important. The control group had higher baseline hospitalisation rates and total costs cautioning interpretation of the result. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0016" title="HeislerM , HoferTP , SchmittdielJA , SelbyJV , KlamerusML , BosworthHB , et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high‐performing health systems. Circulation2012;125:2863‐72. ">Heisler 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in health services utilisation (hospitalisations, primary care visits, ED visits) between intervention and control patients during the 14‐month study of blood pressure control through a clinical pharmacist outreach programme in diabetic patients. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0018" title="HirschJD , SteersN , AdlerDS , KuoGM , MorelloCM , LangM , et al. Primary care‐based pharmacist‐physician collaborative medication‐therapy management of hypertension: A randomized, pragmatic trial. Clinical Therapeutics2014;36(9):1244‐54. ">Hirsch 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The pharmacist collaborative group (PharmD‐PCP MTM) had fewer primary care physician visits during the intervention period than did the usual care group. The mean total combined visits of primary care physician and pharmacist was not greater in the PharmD‐PCP MTM group than in usual care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0019" title="HouwelingST , KleefstraN , vanHaterenKJJ , KooyA , GroenierKH , tenVergertE , et al. Diabetes specialist nurse as main care provider for patients with type 2 diabetes. Journal of Medicine2009;67(7):279‐84. ">Houweling 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a lower number of visits in the NSD group compared with standard care but not in the duration of visits. Significantly more patients were referred back to their GP by the NSD when meeting treatment goals. Personnel and laboratory costs were lower in the intervention group than the control group. The average per month increase in medication costs between the groups was probably not important apart from the cholesterol‐lowering medications. The average time saving per internist was 61.4 minutes (meaning the internist could supervise 11 patients with the NSD in the time he/she could treat one patient). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0020" title="HouwelingST , KleefstraN , vanHaterenKJJ , GroenierKH , Meyboom‐de JongB , BiloHJG . Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. Journal of Clinical Nursing2011;20:1264‐72. ">Houweling 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean number of visits and duration of visits was higher in the practice nurse intervention group than the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0021" title="HuntJS , SiemienczukJ , PapeG , RozenfeldY , MacKayJ , LeBlancBH , et al. A randomised controlled trial of team‐based care: Impact of physician‐pharmacist collaboration on uncontrolled hypertension. Journal of General Internal Medicine2008;23(12):1966‐72. ">Hunt 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total number of clinic visits (physician plus pharmacist) was higher in the intervention arm compared to the control arm. The number of physician visits was lower in the intervention arm. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0022" title="IshaniA , GreerN , TaylorBC , KubesL , ColeP , AtwoodM , et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes. Diabetes Care2011;34:1689‐94. ">Ishani 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no difference in the hospitalisation rate between intervention and control groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0026" title="KuetheM , Vaessen‐VerberneA , MulderP , BindelsP , vanAalderenW . Paediatric asthma outpatient care by asthma nurse, paediatrician or general practitioner: randomised controlled trial with two‐year follow‐up. Primary Care Respiratory Journal2011;20(1):84‐91. ">Kuethe 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In testing the non‐inferiority of asthma care in children with stable asthma provided by a hospital‐based specialised asthma nurse versus a GP or paediatrician, there was little or no differences between the groups for medication, school absence or parental work absence after two years. There was little or no difference in unplanned visits and no hospital admissions during the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0027" title="LitakerD , MionLC , PlanavskyL , KippesC , MehtaN , FrolkisJ . Physician‐nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. Journal of Interprofessional Care2003;17(3):223‐7. ">Litaker 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medium number of outpatient visits were higher for the team based intervention patients. Average personnel costs for one year's treatment were significantly higher in the intervention group (USD 134.68 vs USD 93.70, P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0030" title="MagidDJ , OlsonKL , BillupsSJ , WagnerNM , LyonsEE , KronerA . A pharmacist‐led American Heart Association Heart360 web‐enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes2013;6(2):157‐63. ">Magid 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the mean number of outpatient clinic visits, total number of ED visits, and hospitalisations between the two groups. The intervention group probably had a higher number of email and telephone encounters. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0031" title="MargolisKL , AscheSE , BergdallAR , DehmerSP , GroenSE , KadrmasHM , et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA2013;310(1):46‐56. ">Margolis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Over 12 months in the telemonitoring intervention group all 228 patients used a mean of 11.4 ± 3.9 pharmacist visits lasting a mean of 34.2 minutes and 217 used telemonitoring services with a mean of 9.8 ± 2.5 months of use. It was estimated direct programme costs would total USD 1350 per patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0038" title="SpitzerWO , SackettDL , SibleyJC , RobertsRS , GentM , KeriginDJ , et al. The Burlington randomized trial of the nurse practitioner. New England Journal of Medicine1974;290:251‐6. ">Spitzer 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A reported five per cent drop in gross practice revenue was explained by the absence of billing for services provided by the nurse practitioner. Billing for unsupervised practice was not permitted in Ontario at the time of the study. During the trial year the services rendered by the nurse practitioner were worth approximately USD 16,000 of which almost 50% was for unsupervised practice. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0040" title="TaveiraTH , DooleyAG , CohenLB , KhatanaSA , WuWC . Pharmacist‐led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Annals of Pharmacotherapy2011;45:1346‐55. ">Taveira 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no differences in primary carer visits, use of ED services for all cause visits, diabetes‐related ED visits or hospital admission rates. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0041" title="ThompsonJF , McGhanWF , RuffaloRL , CohenDA , AdamcikB , SegalJL . Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. Journal of the American Geriatrics Society1984;32:154‐9. ">Thompson 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was little or no difference in the average length of stay or hospitalisations although the latter trended lower in the pharmacist group. Differences favouring the pharmacist group were found in the rate of discharge to home or to a lower level of care. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011227-bbs2-0045" title="VivianEM . Improving blood pressure control in a pharmacist‐managed hypertension clinic. Pharmacotherapy2002;22(12):1533‐40. ">Vivian 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Little or no differences between intervention and control groups in appointments with the primary care provider during the 6 months of the study. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>ED: emergency department<br/> GP: general practitioner<br/> NSD: nurse specialised in diabetes </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Secondary outcome ‐ resource use</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/full#CD011227-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011227-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Non‐medical prescribing group versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Systolic blood pressure mmHg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2076</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.76 [‐8.24, ‐5.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.31 [‐6.46, ‐4.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 6 months systolic blood pressure removing cluster effect (Margolis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.13 [‐7.83, ‐4.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 12 months systolic blood pressure excluding cluster trials (Khunti and Margolis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.84 [‐6.29, ‐3.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Systolic blood pressure at 6 months (more NMP prescribing autonomy)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.98 [‐5.36, ‐0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 HbA1c (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 HbA1c 6 mths</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.75, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 HbA1c 12 mths</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>775</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐0.85, ‐0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Low‐density lipoprotein (LDL) mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 LDL 6 mths</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.34, ‐0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 LDL 12 mths</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.29, ‐0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Low‐density lipoprotein pharmacist vs nurse 6 mths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.34, ‐0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Pharmacist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.20, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Nurse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐0.67, ‐0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adherence (continuous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>700</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.00, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adherence (dichotomous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.00, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Health‐related quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Physical component (SF12 or 36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.16, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Mental component (SF‐12 or 36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [‐0.40, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Health facility resource use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Emergency Department visits</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.02, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Hospitalisations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4870</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.01]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Non‐medical prescribing group versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011227.pub2/references#CD011227-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011227.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011227-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011227-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011227-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011227-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011227-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD011227-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011227-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011227\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011227\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011227\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011227\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011227\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6zFwvAqw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011227.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011227.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011227.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011227.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011227.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716004261"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011227.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716004266"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011227.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d94e8a9f09368',t:'MTc0MDcxNjAwNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 